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Abstract
Background: Traditional anesthesia for cardiac surgery involved high opioid use associated with
adverse events and poor outcomes which led to the adoption of multi-modal analgesic
approaches. Although improvements in the overall opioid consumption are seen with multimodal analgesic approaches, recent studies in opioid-sparing anesthesia and regional anesthesia
can further reduce the operative use of opioids in cardiac surgery to improve patient outcomes.
Methods: A comprehensive study search was conducted using CINAHL and MEDLINE
(ProQuest) to identify research studies from the past three years that have focused on opioidsparing anesthesia or opioid-free techniques in patients undergoing cardiac surgery with
cardiopulmonary bypass.
Results: Six research studies were identified as relevant for review. The studies included in this
literature review address opioid-sparing anesthesia in cardiac surgery through different
techniques, investigate the feasibility for implementation, the role of regional anesthesia, and
individual intraoperative pharmacological adjuvants in cardiac surgery requiring
cardiopulmonary bypass (CPB).
Keywords: Opioid-sparing anesthesia, cardiac surgery, cardiac anesthesia, cardiopulmonary
bypass, regional anesthesia, opioid crisis, dexmedetomidine.
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Problem Identification
To the anesthesia provider, the management of both acute and chronic pain is
fundamental as a clinician. Although a multimodal analgesic approach is routinely used by many
anesthesia providers, the use of μ opioid receptor agonists is the current paradigm for acute and
chronic pain management. Despite the current standard, the perioperative use of opioids may
also be detrimental to patient care and may result in opioid-induced side effects including
nausea, emesis, ileus, hyperalgesia, somnolence, pruritus, urinary retention, respiratory
depression, and death. In addition, up to eight percent of opioid-naive patients who undergo
surgery and receive opioids perioperatively may become chronic opioid users.1 This information
has led to the adoption and implementation of non-opioid alternatives and opioid-sparing
anesthesia techniques. However, for the last fifty years opioids have been the mainstay in cardiac
surgeries.2 These major surgeries can involve the coronary arteries, heart valves, or other cardiac
structures that may need to be accessed by the surgeon.
Traditionally, a high-dose opioid induction and maintenance was considered gold
standard for cardiac patients in the 1980s. However, that concept came packaged with side
effects of prolonged mechanical ventilation, increased length of stay in the intensive care unit
and hospital,2 increasing awareness and allowing for other methods to be introduced. Although
providers use a multi-modal approach to analgesia with non-opioid adjuvants, intraoperative
opioid usage ultimately varies between patient, procedure, and anesthesia providers.3 Focusing
on the anesthesia provider, an educational tool on opioid sparing analgesic strategies will help
improve provider knowledge.
Background
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Opioid use and abuse along with addiction has become a significant issue for the last
decade. In fact, opioid overdose in now one of the leading causes of unintentional death in the
United States, surpassing motor vehicle accidents.4 Most surgical patients often receive some
form of opioid narcotic throughout the perioperative period and then postoperatively. Reason
being, that opioids are potent with a rapid onset of action without an analgesic ceiling,4 but with
the increasing use of opioids, it has become a realization that its benefits might be overshadowed
by the potential downsides.5 Researchers have shown that opioid-naïve patients often can
become dependent on narcotic administration after surgery. The anesthesia provider plays a
paramount role in the primary stage of the patient’s exposure to such potent drugs, and therefore
can be a leading agitator to these key issues.
One of the leading causes of the opioid prescription crisis was the call to awareness of
treating pain as the “fifth vital sign”, and idea presented by Dr. James Campbell in 1995. In
1997, the Robert Wood Johnson Foundation funded The Joint Commission to develop pain
standards. Dr. Dennis O’Leary, President of the Joint Commission on Accreditation of
Healthcare Organizations, announced standards for health care organizations to improve pain
management, and emphasized the need for organizations to do systematic assessments and use
quantitative measures of pain.6 This led to a national focus in assessing patients’ perception of
pain; often by practitioners without much experience treating pain.5 Dr. Max emphasized the
conventional wisdom of the day that “therapeutic use of opiate analgesics rarely results in
addiction,” although this was based on only a single publication that lacked detail about how the
study was done.6 Nonetheless, physicians obtained the “green light” to prescribe opioids to
patients that reported high levels of pain on a numerical pain scale. In the 1980’s through 2000’s
in the United States, although the rate of opioid overdose deaths increased drastically, patients
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continued to report the same levels of pain.5 The Centers for Disease Control and Prevention
estimates that the total "economic burden" of prescription opioid misuse alone in the United
States is $78.5 billion a year, including the costs of healthcare, lost productivity, addiction
treatment, and criminal justice involvement.7
The opioid epidemic has allowed for the ability to analyze and make changes to how pain
was being treated. As stated by The Joint Commission, our goal is to ensure that the pendulum of
medical practice does not swing back toward the poor pain control of the past, but instead comes
to rest in a position that balances effective pain treatment with safe opioid prescribing for
individual patients and the general population.6 By improving the knowledge of anesthesia
providers on opioid-sparing analgesic techniques in cardiac surgery, efforts to adhere to the call
of The Joint Commission will remain preserved.
Scope of the Problem
Numerous factors contribute to the current practice of perioperative opioid usage. The
scope of the problem addresses patients undergoing cardiac surgery but also focuses on the
anesthesia provider, and the system or institution. Cardiovascular disease is the leading cause of
global death with an estimated seventeen million deaths per year, and the number is set to
increase to twenty-three million by the year 2030. Coronary artery disease, peripheral vascular
disease, and risk for CAD increase operative risk. Recent myocardial infarction, congestive heart
failure, and aortic stenosis are important risk factors in the anesthetic management of these
patients. Anesthesia for the cardiac patient requires extensive knowledge of the pathophysiology
of the disease process, intraoperative monitoring, and anesthetic management. This includes a
careful selection of anesthetic, analgesic, neuromuscular, and autonomic blocking drugs.8 In the
providers armamenterium, the provider should also be familiar with opioid-sparing strategies to
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decrease opioid consumption and will benefit from current research regarding the use of opioidsparing anesthesia in cardiac surgery. The hospital system or medical institution in which the
provider practices, has a role in the adoption of certain anesthetic techniques. Therefore, a
compilation of evidence and research in the practice of opioid-sparing anesthesia in cardiac
surgery is required for adoption of new policy and the translation of evidence into practice.9
Fortunately, the increasing discussions on the liberal use of opioids during anesthesia care being
called into question, and research is demonstrating that adverse effects limit their effectiveness in
perioperative care.10 An educational intervention tool in this sub facet of cardiac surgery will not
only ensure the anesthesia provider has up-to-date information and the necessary ability to
implement opioid sparing strategies, in an effort to combat the issue of opioid usage and lack of
provider knowledge.
Consequences of the Problem
Cardiac surgery is associated with moderate to severe pain that is related to median
sternotomy, chest tubes, and costovertebral joint distention. Vascular access sites and saphenous
graft harvest sites cause significant pain. Ineffective pain control after major cardiac surgery can
lead to sympathetic activation, resulting in unstable hemodynamics and an increased demand for
oxygen, which is undesirable in cardiac patients with limited reserves.11 Due to this delicate
balance, postoperative pain has been traditionally managed with the use of intravenous opioids.12
However, the use of fentanyl and remifentanil are associated with two clinical phenomena
specific to opioids. The first is antinociceptive tolerance, which is the decrease in the analgesic
activity with a previous exposure to the same or a similar drug. Thus, requiring higher doses to
exhibit the same amount of pain relief. And the second problem is opioid-induced hyperalgesia.
When hyperalgesia is present, prolonged, or acute administration of opioids results in a
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paradoxical decrease in the pain threshold. The lowered threshold causes increases of atypical
pain that appears to be unrelated to the original nociceptive stimulus.13 Other undesired clinical
effects from high narcotic analgesia include respiratory depression, chest wall rigidity, impaired
gas exchange, difficult mask management, gastrointestinal alterations, nausea, vomiting,
inflammation modulation, immunologic alteration, postoperative thermal hyperalgesia, tactile
allodynia, and the need for higher rescue analgesia postoperatively.10,13,14
Despite the associated downsides, opioids remain the primary agents used in most cardiac
surgeries for the treatment of acute and chronic pain.13,15 The lack of provider knowledge on
opioid sparing analgesic strategies intraoperatively in cardiac surgery can have some
unbeknownst negative outcomes of the patients they treat. After implementation of the
educational tool, the anesthesia provider will gain knowledge that can lead to quicker extubation
times, improved cardio protection and decreased postoperative morphine consumption,
indications for which populations to implement opioid-sparing anesthesia, and methods to
prevent some of the overall consequences of habitual intraoperative opioid usage.
Knowledge Gaps
Despite modern enhanced recovery after surgery (ERAS) and fast-track protocols that
aim to reduce opioid usage perioperatively, there is still room for decreasing the use of
intraoperative opioids, even in major cardiac surgery. One potential reason for this knowledge
gap as described by White et al., could be from the wealth of knowledge that is available today to
the clinician. Constant publishing from new journals and research articles can be overwhelming.
For instance, in 1995, it was estimated that clinicians would need to read 19 articles a day, 365
days a year to stay abreast of new clinical information. Today, the challenge to stay current with
the latest research is harder, which speaks to the importance of finding new evidence-based
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practices to bridge this research-practice gap.9 Also, this knowledge gap may be present due to
the existence of conflicting clinical practice guidelines with differing recommendations
regarding the same intervention or population, which tend to undermine the use of the new
findings. One study mentions that although modern fast-track cardiac programs use multimodal
analgesia regimens including paracetamol, non-steroidal anti-inflammatory drugs, and opioids,
the technique has been shown to be suboptimal after pediatric open cardiac surgery. Fifty-two
percent of pediatric patients still report moderate to severe pain on the day of surgery and thirtythree percent experience pain on postoperative day one, along with 42% of patients reporting
vomiting.12
Proposal Solution
To increase knowledge and improve the adoption of opioid-sparing anesthesia amongst
anesthesia providers, demonstrating the effectiveness of opioid-sparing analgesic techniques in
one of the most challenging operating room theatres being cardiac surgery, will help strengthen
the research to practice gap. Opioid-sparing anesthesia does not focus on the use of one single
drug, but instead encompasses a polypharmacy approach to anesthesia and analgesia.
Drugs commonly used include premedication with gabapentin or pregabalin, the
intraoperative use of dexmedetomidine, magnesium, lidocaine, ketamine, and postoperative
medication such as paracetamol, diclofenac, intravenous ibuprofen, and IV acetaminophen.
Opioid-sparing anesthesia is paired with regional anesthesia to control pain transmission,
decrease opioid use, emphasize early extubation, and mobilization.2,13
Several opioid-sparing techniques have recently been published in major cardiac surgery
requiring on-pump cardiopulmonary bypass in both adult and pediatric populations. One 2019
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study focused on the effects on opioid-free anesthesia on CABG surgery postoperatively.10 The
use of intraoperative dexmedetomidine was not used in the first study but included in the 2021
study focused on the feasibility of dexmedetomidine in CABG surgery requiring CPB.16 In the
both studies the reduced opioid group was associated with lower morphine consumption,
shortened intubation times, and decreased ICU stay.13 Additionally, the second study mentions
that the protocol used could reduce opioid consumption when compared to the multi-modal and
ERAS approaches by half, and also revealed that dexmedetomidine reduced the incidence of
new-onset atrial fibrillation, has myocardial protective qualities, and is associated with a
decreased incidence of postoperative delirium.16
Regarding the pediatric population, in 2020 Wolters Kluwer published an article with an
opioid-sparing ERAS protocol using a single dose of IV methadone in children undergoing
major cardiac surgery requiring CPB. Methadone, lidocaine, and ketamine boluses were given
prior to incision, then ketamine and lidocaine were continued for maintenance. Prior to
emergence, a regional parasternal infiltration with ropivacaine 0.2% was completed and IV
acetaminophen bloused. Of the 24 participants in the study, no child required supplemental
opioid intraoperatively, and all but one child was extubated on the OR table.17 In 2019, the
British Journal of Anaesthesia published a study on dexmedetomidine aimed in determining the
safety of usage in neonates and infants undergoing cardiac surgery on CPB, and concluded that
dexmedetomidine can be a feasible addition to the anesthetic regimen, and results in low
incidence and severity of adverse safety events in infants undergoing cardiac surgery with
cardiopulmonary bypass and validates the pursuance of opioid-sparing modalities in the pediatric
population and major cardiac surgeries.18
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As previously discussed, the use of regional anesthesia in cardiac surgery along with
opioid-sparing use has also been the topic of research with multiple studies having described
major success in mitigating the use of opioids with an erector spinae plane block in both the
pediatric and adult population.12 ESPB is an inter-fascial plane block where local anesthetic is
injected beneath the iliocostalis, longissimus, and spinalis muscles to achieve analgesia for
pediatric thoracic, cardiac, or abdominal surgery. The effect appears to be due to local anesthetic
spread close to the paravertebral space, reaching the dorsal and ventral rami of the thoracic spinal
nerves that cover dermatomes, which include the midline sternotomy. The ESPB achieves local
anesthetic diffusion to the thoracic paravertebral space when the anesthetic solution is located in
between the erector spinae muscles and the paravertebral compartment.12 In one study, the ESPB
was done preoperatively with catheters in place for redosing ropivacaine along with an
intraoperative multimodal opioid free approach using dexmedetomidine, ketamine, magnesium,
and esmolol, allowed the patient to be extubated after CPB. A single dose of oxycodone was
given to the patient in the ICU.17
Conducting a thorough literature analysis will provide anesthesia providers with the most
up-to-date information possible. The findings are correlative with recent literature and appear to
be of vast significance in the development of opioid-sparing anesthetic techniques with benefits
in multiple surgical procedures, and in various patient populations. This project will include an
educational intervention to improve the knowledge of anesthesia providers in opioid sparing
strategies; more specifically, in major cardiac surgery requiring cardiopulmonary bypass.
Methodology
Eligibility Criteria
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Studies evaluated for this literature review were chosen based on the inclusion and exclusion
criteria set to best discern the objectives. Inclusion criteria included only studies written in
English with full-text availability. Exclusion criteria included the studies where subjects were
undergoing non-cardiac surgeries using opioid-sparing anesthesia. The studies included for
review focus on the open-heart surgery requiring on-pump or off-pump CPB. Clinical database
sources used to guide research were accessed via Florida International University library
services.
Information sources
Based on the clinical question, the following search keywords were identified using the
appropriate Boolean operators and search symbols: Opioid sparing anesthesia, Coronary Artery
Bypass Graft, Opioid-free anesthesia, and Cardiac surgery. The databases utilized for the search
included The Cumulative Index to Nursing and Allied Health Literature (CINAHL) and
MEDLINE (ProQuest)
Search Strategy
The key search terms were further expanded to include: (“Opioid free anesthesia” OR
Nonopioid anesthesia” OR “OFA” OR Opioid Sparing OR Dexmedetomidine OR ESPB OR
Regional anesthesia) AND (“Cardiac surgery” OR “Heart surgery” OR “Coronary artery bypass”
OR Cardiovascular OR Cardiopulmonary bypass OR Valve surgery) The CINAHL search
yielded 434 articles and MEDLINE produced 4,299 articles. To ensure the most relevant and
recent articles were reviewed, only articles published from 2018 to 2021 and those written in
English were included. This yielded 625 for MEDLINE and 119 articles for CINAHL. Duplicate
articles were removed, and the CINAHL search was narrowed even further. Titles were excluded
if they did not meet inclusion criteria. Articles that included the use of nonopioid drugs solely in
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the postoperative phase were excluded. Studies that were not completed or letters to the editors
were excluded from further review. The populations accepted included neonates, pediatrics, and
adults.

"Opioid sparing
anesthesia" OR
"nonopioid" OR
"Opioid Free" OR
"OFA", OR
"Dexmedetomidine"
OR "ESPB

Diagram 1. Search Keywords

“Cardiac surgery”
OR “heart surgery”
OR "Cardiovascular"
OR “Coronary artery
bypass” OR
"Cardiopulmonary
bypass" OR "valve
surgery"

15
Author(s)

Guinot et al.
(2019)

Purpose

Methodology
/ Research
Design
To demonstrate the Retrospective
feasibility of an
matched
opioid-free
cohort study,
anesthesia (OFA)
Level III
protocol in cardiac
surgery to improve
patient care.
To demonstrate
that compared with
OA, OFA lowers
postoperative
morphine
consumption.
To evaluate the
effect of OFA on
operative
hemodynamic
stability,
postoperative
complications
assessed by a
composite criterion
and the length of
stay (LOS) in the
ICU and in hospital.

Intervention(s)/
Measures

Sampling/Setting

Primary Results

Relevant Conclusions

Retrospective
matched cohort
study on cardiac
surgery patients
with
cardiopulmonary
bypass between
2018 and 2019.
Patients were
divided into two
groups: OFA
(lidocaine,
dexamethasone
and ketamine) or
opioid anaesthesia
(OA) (sufentanil).

Participants were
18 or over requiring
cardiac surgery
with the use of
cardiopulmonary
bypass (CPB),
coronary artery
bypass grafting
(CABG), the surgical
correction of valve
disease (aortic,
mitral), combined
surgery (CABG and
valve disease),
ascending aortic
disease, and left
ventricular assist
device
implantation). The
exclusion criteria
were off-pump
cardiac surgery,
preoperative
analgesic use,
gabapentin use,
antidepressant
therapy and
preoperative

The total morphine
consumption was higher in
the OA group than in the
OFA group (15 (6–34) vs 5
mg (2–18), p = 0.001). The
pain score during the first
48 post-operative hours
did not differ between the
two groups. Creatinine
values did not differ on the
first post-operative day (80
(IQR: 66– 115) vs 77
mmol/l (IQR: 69–95), p =
0.284). Incidence of the
composite endpoint was
lower in the OFA group (25
patients (43%) vs 38
patients (68%), p = 0.021).
The time to extubation and
the ICU stays were shorter
in the OFA group (3 (1–5)
vs 5 (3–6) hours, p = 0.001
and 2 (1–3) vs 3 (2–5) days,
p = 0.037).

The use of OFA was
associated with lower
morphine
consumption. OFA
might be associated
with shorter intubation
time and ICU stays.
OFA might have
beneficial effects of on
the post-operative
course of patients
undergoing cardiac
surgery with CBP

16
cognitive
dysfunction.

Aguerreche
et al., (2021)

To investigate a
dexmedetomidinebased opioid-free
anesthesia (OFA)
protocol in cardiac
surgery. The main
objective of this
study was to
evaluate the
feasibility and the
postoperative
opioid- sparing
effect of
dexmedetomidinebased OFA in adult
cardiac surgery
patients.

Retrospective
review.
Level III

A retrospective
review was
performed on
patients who
underwent onpump cardiac
surgery between
November 2018
and February 2020.
The primary
endpoint was the
total amount of
opioid consumed in
its equivalent of
intravenous
morphine during
the first 48
postoperative
hours. Secondary
outcomes included
perioperative

110 patients met
criteria for
inclusion in the
study, 55 in the OA
group and 55 in the
OFA group.
80 patients were
divided into two
groups: OFA
(lidocaine,
ketamine,
dexmedetomidine,
MgSO4) or opioidbased anaesthesia
(remifentanil and
anti- hyperalgesic
medications such
as ketamine and/or
MgSO4 and/or
lidocaine at the
discretion of the
anesthesiologist).

The median total amount
of opioid consumed in its
equivalent of intravenous
morphine during the first
48 postoperative hours was
lower in the OFA group
(15.0 mg [8.5–23.5] versus
30.0 mg [17.3–44.3], p <
0.001). While no
differences were seen with
rest pain (2.0 [0.0–3.0]
versus 0.5 [0.0–5.0], p =
0.60), the maximal pain
score during coughing was
lower in OFA group (3.5
[2.0–5.0] versus 5.5 [3.0–
7.0], p = 0.04). In OFA
group the incidence of
atrial fibrillation (18%
Patients
versus 40%, p = 0.03) and
undergoing offnon-invasive ventilation
pump cardiac
surgery and/or with use (25% versus 48%, p =
0.04) were lower. The
pre-operative
incidence of bradycardia

Dexmedetomidinebased OFA in cardiac
surgery patients is
feasible and could be
associated with a lower
postoperative
morphine consumption
and better
postoperative
outcomes. Further
randomized studies are
required to confirm
these promising results
and determine the
optimal associations,
dosages, and infusion
protocols during
cardiac surgery.
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Kaushal et
al., (2020)

To test the
hypothesis that the
administration of
bilateral ESPB with
ropivacaine 0.2%
would improve
postoperative
analgesia after
pediatric cardiac
surgery. The
requirement of
additional rescue
analgesic
medication and
adverse events
associated with
ESPB also were
studied.

Prospective,
randomized,
single-blind,
comparative
study
Level III

hemodynamics,
post-operative
maximal pain at
rest and during
coughing and
adverse outcomes.
Data are expressed
as median.

hemodynamic
instability and/or
with atrioventricular block
grade 2 or 3 and/or
hypersensitivity to
opioids were
excluded.

and the intraoperative use
of norepinephrine were
similar between both
groups.

The subjects were
allocated randomly
into 2 groups: ESPB
(group B, n = 40)
received ultrasound
guided bilateral
ESPB at the level of
T3 transverse
process and control
(group C, n = 40)
receiving no block.

Eighty children with
acyanotic
congenital heart
disease undergoing
cardiac surgery
through midline
sternotomy.

Group B demonstrated
significantly reduced
MOPS as compared with
group C until the 10th
postoperative hour (p <
0.0001), with comparable
MOPS at the 12th hour.
The consumption of
postoperative rescue
fentanyl was also
significantly less in group B
in comparison to group C
(p < 0.0001) with a longer
duration to first rescue
dose requirement in group
B. In addition, the group B
showed lower
postoperative sedation
scores and intensive care
unit stay in contrast to
group C.

The postoperative
pain was assessed
using Modified
Objective Pain
Scores (MOPS)
which were
evaluated at 0, 1, 2,
4, 6, 8, 10, and 12

Patients with
preoperative
ejection fraction
<35%, low-cardiacoutput syndrome,
recurrent
ventricular
arrhythmias,
preoperative
inotropic support,
allergic to the
amide type of local
anesthetics (LA),

Ultrasound-guided
bilateral ESPB presents
a simple, innovative,
reliable, and effective
postoperative
analgesic modality for
pediat- ric cardiac
surgeries
contemplated through
a midline sternotomy.

18
hours after
extubation

Macaire et
al., (2020)

To determine if
bilateral ESPB with
a programmed
intermittent bolus
(PIB) regimen
decreases
postoperative
morphine
consumption at 48
hours and improves
analgesia in
children who
undergo cardiac
surgery.

Randomized,
double-blind,
placebocontrolled
trial
Level III

Children who
underwent cardiac
surgery through
midline sternotomy
randomly allocated
into two groups:
ultrasound- guided
bilateral ESPB at
the level of T3–T4
transverse process
then PIB with saline
infusion (group 1,
n=23) or PIB with
0.2% ropivacaine
(group 2, n=27).
Intravenous
morphine at 30
μg/kg/hour was
used as rescue
analgesia

requiring
intubation for more
than 3 hours or reexploration, and
requiring redo or
emergency
surgery were
excluded from the
study.
This randomized,
double-blind,
placebo-controlled
study was
performed from
August 2018 to
March 2019,
initially with 104
children with an
American Society of
Anesthesiologists
physical status class
II scheduled for
cardiac surgical
procedures through
midline sternotomy
at Vinmec Central
Park International
Hospital, Ho Chi
Minh City, Vietnam.
Exclusion criteria
were as follows:

The total dose of morphine
in 48 hours was
significantly decreased in
patients receiving a
bilateral ESPB with
ropivacaine (120±320
μg/kg) compared with
patients with saline
infusion (512±560 μg/kg;
p=0.03). Fourteen per cent
of patients required rescue
analgesia with morphine in
group 2 compared with
41% in group 1 (p=0.05).
The patients in group 2
demonstrated significantly
reduced COMFORT-B
scores at extubation, drain
removal, and mobilization
compared with those
in group 1 and had
reduced FLACC scale levels

In pediatric cardiac
surgery, the results of
this study confirms
that bilateral ESPB
analgesia with
ropivacaine decreases
the postoperative
morphine consumption
at 48 hours and
demonstrates better
postoperative
analgesia compared
with a control group.
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Iguidbashian
et al., (2020)

Assess the efficacy
and safety of a
multimodal pain
regimen centered
around single‐dose
intraoperative IV
methadone in
pediatric cardiac
surgical patients.

Retrospective
analysis,
Level III

Postoperative pain
was assessed using
the COMFORT-B
score for
extubation, drain
removal, and
mobilization, and
the FLACC (Face,
Legs, Activity, Cry,
Consolability) scale
at 0, 2, 4, 6, 8, 12,
16, 20, 24, 36, and
48hours after
surgery. Adverse
events were noted.
A retrospective
analysis of all
pediatric cardiac
surgical patients for
whom early
extubation was
intended. A
multimodal
analgesic regimen
was used for all
patients, consisting
of methadone (0.2–
0.3 mg/kg),
ketamine (0.5
mg/kg plus 0.25
mg/kg/h), lidocaine

the patient’s family
refused, a
preoperative
ejection fraction
<35%, ventricular
arrhythmia/dysrhyt
hmia, preoperative
inotropic support,
redo or emergency
surgical
procedures, and an
allergy to amidetype LAs.

at 20 and 24 hours
postoperatively (p=0.05
and p=0.001, respectively).
No differences were
reported for extubation
and drain removal times or
for length of hospital stay.
In addition, vomiting
episodes were decreased
in group 2 (p=0.01).

A total of 24
children were
included in the
study. Fifteen were
male; 22 had
procedures
performed on
bypass, and 11
involved a reentry
sternotomy. The
youngest and
smallest patient
was 8 months old
and weighed 6.2
kg. Four patients

None of the children
required intraoperative
supplemental opioids; 23
(96%) were extubated in
the operating room.

A methadone‐based
multimodal regimen
facilitated early
extubation without
appreciable adverse
events. Further
Time to first supplemental investigations are
opioid administration was needed to confirm
5.1 (3.5–9.5) h. Cumulative efficacy of this regimen
total supplemental opioids and to assess whether
(in intravenous morphine
the excellent safety
equivalents) at 24 and 72 h profile seen here holds
were 0.2 (0.09–0.32) and
in the hands of
0.42 (0.27–0.68) mg/kg.
multiple providers
caring for a larger,
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(1 mg/kg plus 1.5
mg/kg/h),
acetaminophen (15
mg/kg), and
parasternal
ropivacaine (0.5
mL/kg of 0.2%).

Ming et al.,
(2021)

This study aimed to Randomized
investigate the
Controlled
effects of
Trial
dexmedetomidine
on hemodynamics
and organ
protection in
congenital heart
disease (CHD)
children who
underwent openheart surgery under
cryogenic
cardiopulmonary
bypass.

Average
methadone dosing
was 0.26 (0.23–
0.29) mg/kg
90 children were
randomly allocated
to group C (0.9%
saline 0.2
mg/kg/hour), group
D1
(Dexmedetomidine
0.2 mcg/kg/hour),
and group D2
(Dexmedetomidine
0.4mcg/kg/hour)
(n=30 per group).
All participants
received fentanyl,
propofol and 1%
sevoflurane for
anesthesia
induction.
Hemodynamic data

had single‐ventricle
physiology

One child required
more heterogeneous
postoperative bilevel
population.
positive airway pressure
support, but none required
reintubation. None had
pruritus; three (13%)
experienced nausea

Children who were
scheduled for
repair of
atrioventricular
septal defect
during CPB under
elective general
anesthesia were
enrolled in this
study from July 1st,
2017 to February
28th, 2018 at the
Ruikang Hospital of
Guangxi University
of Traditional
Chinese Medicine.

Compared with group C,
group D1, and D2
exhibited reduction in
hemodynamic parameters,
myocardial and brain
injury indicators, and
tracheal extubation time.
There were no significant
differences in blood urea
nitrogen and neutrophil
gelatinase- associated
lipocalin or incidence of
AKI among the 3 groups.
Besides, the incidence of
tachycardia, nausea,
vomiting and moderate
agitation, and the FLACC
scale in group D1 and D2

Patients aged 1 to
6years, diagnosed

Anesthesia with
dexmedetomidine can
effectively maintain
hemodynamic stability
and diminish organ
injuries in CHD
children.
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were measured
from T0 (before the
induction) to T7 (30
minutes after
extubation). The
difference of
arterial internal
jugular vein bulbar
oxygen difference
and cerebral
oxygen extraction
ratio were
calculated
according to Fick
formula. Enzymelinked
immunosorbent
assay was
performed to
detect the serum
myocardial, brain
and kidney injury
markers. The
incidence of acute
kidney injury (AKI)
was calculated by
serum creatinine
level. Tracheal
extubation time,
postoperative pain
score and

with CHD or AVSD, were lower than those in
with an ASA class II- group C.
III.
Dexmedetomidine 0.4
Patients with
g/kg/hour could further
severe malnutrition reduce the dosage of
and cyanosis were
fentanyl and dopamine
premature and low compared with Dex
birth weight;
0.2g/kg/hour.
2. a previous
cardiac surgery;
3. allergic to
narcotic drugs;
4. pulmonary
hypertension;
5. combined with
cerebral palsy,
severe renal or
hepatic
disorders,
metabolic
dysfunction, or
other congenital
diseases affecting
the brain, liver, and
kidney, such as
Trisomy 21
syndrome were
excluded from the
study.
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emergence
agitation score
were also recorded
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Results of Literature
Study Characteristics
The articles reviewed are centered on cardiac surgery requiring cardiopulmonary bypass
along with measurable outcomes during the intraoperative and postoperative phases of their
surgical management. Three articles are retrospective studies (Aguerreche et al., Guinot et al.,
and Iguidbashian et al.), two articles are RCTs (Macaire et al. & Ming et al.) with Macaire et al.
being a double-blind and placebo-controlled trial. The last study is a prospective, randomized,
single-blind, comparative study (Kaushal et al.). Subjects in the retrospective studies were
analyzed before and after intervention without randomization.
The articles analyzed the feasibility of opioid-sparing anesthesia techniques in open-heart
surgery. The study methods by Macaire et al. and Kushal et al. analyzed the use of regional
anesthesia with ESPB blocks to reduce opioid consumption postoperatively. Guinot et al.,
Aguerreche et al., and Iguidbashian et al. analyzed the use of a non-opioid-based anesthetic
regimen during heart surgery on CPB in efforts to minimize opioid administration while
analyzing the feasibility of an opioid spared approach. The article Aguerreche et al. specifically
focused on the use of dexmedetomidine intraoperatively as an IV infusion, and Iguidbashian et
al. focused on the pediatric population with a focus on the postoperative minimization of opioids.
The final study by Ming et al. offers further support for the use of opioid-sparing anesthesia in
children with congenital heart disease. Lastly, in the single-blind comparative study by Kaushal
et al., subjects were analyzed before and after intervention without randomization.
Summary of the Evidence
This 2019 study by Guinot et al. is the first of its kind to specifically focus on the
feasibility of OFA in cardiac surgery undergoing CPB. The findings by Guinot et al. supporting
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the use of OFA, or a minimal opioid approach in cardiac surgery became the basis for further
studies such as that by Aguerreche et al. The retrospective study by Aguerreche et al.
demonstrates the potential for dexmedetomidine as the foundation in an opioid-sparing
anesthesia approach to cardiac surgery. Dexmedetomidine offered numerous benefits in the
cardiac patient having cardiac surgery and compounded to the information presented in the
article by Guinot et al., which focused on the use of other non-opioid adjuvants without
dexmedetomidine (due to unavailability) in open-heart cardiac surgery.
Multiple articles supported the use of regional anesthesia in the preserving opioid usage,
however the ESPB offered multiple advantages, as demonstrated in the study by Kaushal et al.
The article was chosen for literature review as it demonstrated the ability of the ESPB to have a
major opioid-sparing effect in cardiac surgery. The bilateral ESPB as a newer regional technique
in cardiac surgery proved to reduced opioid consumption, demonstrated efficacy, was safe, and
simple to implement for the anesthesia provider. The following article by Macaire et al. provided
further insight into the opioid-sparing effects of bilateral ESPB in cardiac surgery. Where the
article by Kaushal et al. demonstrated the analgesic benefits to using the ESPB in pediatric
cardiac surgery, Macaire et al. found that the addition of PIBs of ropivacaine can further prolong
analgesia and diminish post-operative morphine consumption beyond 12 hours (Kaushal et al.) to
48 hours without causing LA systemic toxicity in pediatric cardiac patients undergoing openheart surgery via midline sternotomy.
The article by Iguidbashian et al. is one of the first to propose the use of IV methadone as
the cornerstone of an analgesic regimen in pediatric cardiac surgery. Iguidbashian et al. focused
on the use of methadone in the pediatric cardiac population versus the use of more traditional
approaches using short-acting analgesics and explains that in traditional methods, pain levels

Page 24 of 91

25
tend to wax and wane in relation to the varying plasma drug levels. Iguidbashian et al.
hypothesized that methadone due to its long duration of action of approximately 24-36 hours
may provide steadier, basal pain control during the period of greatest surgical pain. Alternatively,
methadone also displays antagonizing effects on the N-methyl-D-aspartate (NMDA) receptor,
may prevent the hyperalgesia related to chronic pain syndrome, and has fewer respiratory side
effects19 when compared to other rescue analgesics such as fentanyl, morphine. Also, of the
articles reviewed for inclusion of the literature review, the intraoperative approach to this study
is amongst the most opioid sparing by design with the inclusion of dexamethasone, ketamine,
lidocaine, acetaminophen, ketorolac, and regional anesthesia, with a focus in OR on-table
extubation.
Having adequate information to start an implementation guide based on
dexmedetomidine, regional anesthesia with ESPB, and methadone as an alternative to short
acting opioids, the study by Ming et al. solidifies the use of a dexmedetomidine based opioidsparing anesthesia in cardiac surgery with the findings that dexmedetomidine at a rate of
0.4mcg/kg/hr is clinically safe and diminishes organ injuries in children undergoing open-heart
surgery. Ming et al. explained the strong physiological stress response that is seen during openheart surgery. For instance, when the ascending aorta is blocked during CPB it significantly
diminishes normal blood perfusion to various organs of the body. Meanwhile, the blood in CPB
is directly exposed to extracorporeal circulation pipeline and oxygenator, resulting in the
generation of numerous inflammatory cytokines and cascade release, which can precipitate
systemic inflammatory response syndromes. Hyperglycemia and hyperlacticacidemia are caused
by this strong stress response, and hemodynamic instability during surgery can cause ischemia
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and reperfusion injuries. These hemodynamic and physiologic changes can cause organ damage
to the heart, lung, brain, and kidneys.
As opioid-sparing cardiac surgery gains popularity and interest, there will be more
randomized controlled trials about opioid-sparing anesthesia in cardiac surgery. Sorting through
search findings in the CINHAL database, numerous case reports validated the methods described
above. One example is the Elsevier published case report in the Journal of Cardiothoracic and
Vascular Anesthesia on opioid-free ultra-fast-track CABG surgery using ESPB catheters.15 The
case report describes a 74-year-old male undergoing CABG surgery with similar anesthetic
approaches to those described by Guinot et al., Aguerreche et al., and Iguidbashian et al. with the
use of versed, ketamine, propofol, ketamine, and magnesium for the induction of anesthesia,
followed by bilateral ESPB with ropivacaine, acetaminophen IV and on-table extubation. In this
case report the patient received a total 10 mg oral oxycodone for postoperative pain. A recent
2021 case report from Turkey by the Anesthesia and Pain Management Journal12, describes a
similar anesthetic regimen that mainly excluded the use of opioids from the preoperative phase to
postoperative in three cardiac patients. Two patients were undergoing CABG surgery and the
third patient underwent mitral valve repair, all which were successful under CPB. The ESPB
were bilateral with catheters left in place for postoperative ropivacaine infusions. This case
report used tramadol as a rescue analgesic versus morphine or fentanyl which was only used in
one of the three patients. Unfortunately, these are only case reports and thus were not included in
the literature review and are thus a limitation in this review. Further clinical studies are needed to
validate the results; however, these two case reports encompass the use of opioid-sparing
techniques throughout the perioperative course and includes the ESPB with the epidural catheters
for programmed infusions of ropivacaine. The limited amount of research available on opioid-
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sparing anesthesia in open-heart cardiac surgery is inherently a limitation to this review. Of the
research available, the consensus is that larger, randomized clinical trials are needed to validate
the findings
Results of Individual Studies
The first article by Guinot et al.10 explored the feasibility of opioid-free anesthesia (OFA)
protocol in cardiac surgery to improve patient care and then evaluate the end-effect on
postoperative morphine consumption and the post-operative course. This retrospective matched
study looked at cardiac surgery patients with CPB between 2018 and 2019 that were over the age
of eighteen requiring coronary bypass grafting, or valve surgery (aortic, mitral), and or combined
coronary and valve surgery. The exclusion criteria were off-pump cardiac surgery, preoperative
analgesia use, gabapentin use, antidepressant therapy, and preoperative cognitive dysfunction.
110 patients were matched and were divided into two groups: 55 individuals in the OFA group
and 55 individuals in the opioid anesthesia (OA) group. In the OA group, anesthesia was induced
with an intravenous bolus of ketamine (0.3-0.5mg/kg), propofol (0.4-2mg/kg), and sufentanil
(0.5ng/ml) until the loss of eyelash reflex. Sufentanil was continuously infused using Schneider’s
target-controlled infusion model. Also, in the OA group, all patients had regional anesthesia by
serratus anterior plane block or a continuous parasternal infusion of a local anesthetic. None of
the participants in the OA group received lidocaine. In the OFA group, the anesthetic regimen
consisted of an intravenous bolus of dexamethasone (0.1mg/kg), an intravenous bolus of
ketamine (0.3-0.5mg/kg) intravenous bolus of lidocaine (1.5mg/kg 15 minutes before the start of
propofol), and propofol (0.4-2mg/kg) until the loss of eyelash reflex. Lidocaine was continuously
administered at 1.5mg/kg/h until the end of surgery. In both groups, intubation was facilitated
with the use of cisatracurium (0.15mg/kg) and neuromuscular blockade was ensured using
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peripheral nerve stimulation, intermittent boluses were given as needed. The methods used
during the time of CPB and ICU management are well documented and clearly explained and
remain consistent in both groups to preserve the integrity of the study.
Postoperative analgesia management comprised intravenous paracetamol (1g every 6
hours) and morphine-based patient-controlled analgesia (PCA). Before extubation, all patients
received 1 gram of acetaminophen. The study demonstrated a significant difference in the
postoperative morphine doses between the OFA and OA groups (5mg vs 15 mg). However,
complementary analgesia did not differ significantly. The complementary use of ketoprofen,
nefopam, and tramadol remained the same between the two groups. Guinot et al. revealed two
findings, one, that the OFA group was associated with lower postoperative morphine
consumption, higher operative use of antihypertensive medications, a decrease in orotracheal
intubation time including the use of non-invasive respiratory support, and shorter intensive care
unit stays. Guinot et al. revealed that dexmedetomidine was not used because it was not available
in their department but would have offered several advantages. For example, the combination of
dexmedetomidine usage with lidocaine can lead to better postoperative pain relief with a quote
by a recent meta-analysis confirming that dexmedetomidine provides good hemodynamic
stability with less hypertension and tachycardia.
Limitations to the study include the study method a single retrospective study, which has
inherited design-related limitations. Guinot et al., described a second limitation being despite
protocol management for sedation and analgesia, biases may have been introduced by the
attending physicians and nursing staff. For example, some patients received analgesia in addition
to patient-controlled morphine analgesia. To improve on these limitations, controlled randomized
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studies can confirm the results that opioid-sparing use in cardiac surgery may be beneficial in
cardiac surgery with CPB.
The second article included in this literature review was published by BMC
Anesthesiology in 2021 by Aguerreche et al.16 This study explored the feasibility and
postoperative opioid-sparing effect of an OFA approach in cardiac surgery. This study takes the
recommendations from Guinot et al. and implements a dexmedetomidine-based approach to
opioid-sparing anesthesia. The purpose of the article is disclosed with the research question
supporting the hypothesis that dexmedetomidine-based OFA could significantly reduce
morphine consumption within the first 48h following on-pump cardiac surgery. The design
methods are a retrospective and single-center study conducted in Bordeaux, France that analyzed
patients from November 2018 to February 2020. The patients were broken down into two
groups, one the OFA group, and the second, the opioid-based group (OBA). 2108 patients
underwent on-pump CPB during the time frame; however, it was reduced to 80 patients divided
into two groups of 40 with similar statistical variables between them such as similar surgical
procedures with equivalent CPB duration. Exclusion criteria included patients undergoing offpump cardiac surgery, preoperative hemodynamic instability, atrioventricular block grade 2 or 3,
and patients with hypersensitivity to opioids.
Intraoperative management for both groups included routine monitoring (five-lead ECG,
pulse oximeter, non-invasive arterial pressure) upon arrival to the operating room. A peripheral
venous catheter and an arterial catheter were inserted under local anesthesia. After induction of
anesthesia, hemodynamic monitors were completed with the insertion of a triple lumen central
venous catheter (CVC) in the right internal jugular vein for the infusion of drugs and to monitor
the central venous pressure.
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In the OBA group, anesthesia was based on simultaneous propofol and remifentanil
targeted-controlled infusions using the Schnider and the Minto models. Induction of anesthesia
was maintained via target-effect site concentrations for propofol and remifentanil. For
maintenance, concentrations of propofol and remifentanil were adapted to maintain the bispectral
index (BIS) value between 40 and 60 and to maintain mean arterial pressure (MAP) between 60
and 85 throughout the surgery. A bolus of morphine of 0.10-0.15mg/kg was given 30 minutes
before the anticipated end of surgery for postoperative analgesia. The addition of nonopioid
adjuncts such as ketamine, lidocaine, or magnesium sulfate in the OBA group was left at the
discretion of the attending anesthetist.
In the OFA group, a pre-induction mixture of IV boluses of dexmedetomidine (0.3-0.6
mcg/kg), magnesium sulfate (3g over 15min), dexamethasone (0.1mg/kg), and lidocaine
(1.5mg/kg) were given over 15 minutes. A bolus of ketamine (0.3 mg/kg) was followed by
continuous infusion (0.25mg/kg/hr), which was stopped at surgical wound closure. Propofol was
used for induction and then used in maintenance via TCI infusion. After induction, a continuous
infusion of dexmedetomidine was adapted to MAP values. If MAP was below 55 mmHg,
dexmedetomidine was discontinued. Conversely, if MAP was higher than 90 mmHg and the BIS
between target values, dexmedetomidine was increased up to 0.5 mcg/kg/hr. In both groups, the
use of regional anesthesia was not performed. Aguerreche et al. described the specifics of the
CPB machine and methods used during this period in the surgery. Both groups received a bolus
of nefopam 30 min before the end of surgery and infusion. Also, paracetamol 1gm every 6 hours
was administered. In both groups, all medications were stopped at the end of surgical dressing
except for propofol which was continued in all patients for the ICU transfer.
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Aguerreche et al. revealed the total amount of opioids consumed in its equivalent of IV
morphine during the first 48 postoperative hours was significantly lower in the OFA group
compared to the OBA group (15mg vs. 30mg). Maximal pain scores were similar between both
groups and but were lower in the OFA regarding postoperative coughing. Patients in the OFA
group also had a lower incidence of atrial fibrillation and required less non-invasive ventilation.
The author supports the hypothesis that a dexmedetomidine-based OFA regimen is feasible in
cardiac surgery, has a “statistically significant” opioid-sparing effect, and can be associated with
better postoperative outcomes including less new-onset atrial fibrillation, a lower rate of
postoperative invasive ventilation use, and a decreased incidence in postoperative delirium.
Dexmedetomidine was discontinued in 10 patients due to a MAP less than 55.
There are limitations of this study mainly due to the nature of its retrospective design.
The low number of patients in this study limits external validity. The author also mentions that
the inclusion of remifentanil in the OBA group is a limitation because of its potential to cause
postoperative hyperalgesia. Also, the patients that received postoperative ketamine boluses in the
OBA group, the ketamine cannot be converted to morphine equivalents for comparison. The
author suggests that for future research, a controlled prospective randomized study will confirm
the current results. Despite dexmedetomidine being discontinued in 10 patients, the author quotes
other articles that support the use of dexmedetomidine in cardiac surgery due to its opioidsparing effects via spinal and non-spinal mechanisms, its ability to have a protective effect in onpump CABG by decreasing myocardial ischemia-reperfusion and improving myocardium
perfusion, anti-inflammatory, sympatholytic and parasympathomimetic effect. The author
concludes the article by strongly suggesting that dexmedetomidine-based opioid-sparing
anesthesia in cardiac surgery is feasible and provides intraoperative hemodynamic stability.
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The third study in the literature review is the 2019 study published by the Journal of
Cardiothoracic and Vascular Anesthesia by Kaushal et al.20 The title of Efficacy of Bilateral
Erector Spinae Plane Block in Management of Acute Postoperative Surgical Pain After Pediatric
Cardiac Surgeries Through a Midline Sternotomy. The prospective, randomized, single-blind
study aims to explore the role of a newer regional anesthetic technique involving the erector
spinae fascial plane; the erector spinae plane block (ESPB) in pediatric cardiac surgery. The
author tests the hypothesis that the administration of bilateral ESPB with ropivacaine 0.2%
would improve postoperative analgesia after pediatric cardiac surgery after midline sternotomy.
Patients were selected after explaining the study protocol and obtaining written consent.
100 participants with an American Society of Anesthesiologists physical status class I and II
were selected. Children excluded were those with a preoperative ejection fraction less than 35%,
low-cardiac-output syndrome, recurrent ventricular arrhythmias, preoperative inotropic support,
allergic to amide local anesthetics, requiring intubation for more than 3 hours or re-exploration,
and patients requiring redo or emergency surgery. The enrolled children were subsequently
randomized into 2 groups using a computer-generated random number table: group B receiving
bilateral ESPB with 0.2% ropivacaine and group C without any intervention. The postoperative
pain was managed with rescue IV fentanyl. Both the groups received IV acetaminophen 15
mg/kg every 8 hours as a component of multimodal analgesia. Preoperatively all patients
received 1mg/kg of promethazine syrup one hour before surgery. Induction was standardized
with an inhalation induction with sevoflurane in 50% oxygen and air mixture, followed by
peripheral IV cannulation of appropriate size. Midazolam was given IV 0.05-0.1mg/kg, fentanyl
1-2mcg/kg, and rocuronium, 0.6mg/kg, to facilitate endotracheal intubation. After arterial and
central venous catheter placement, the child was placed in the right lateral decubitus position to
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facilitate the ultrasound guided ESPB. A high-frequency linear ultrasound was used in a
longitudinal direction over the T3 transverse process lateral to the spinous process. The identified
muscles for the ESPB include the trapezius, rhomboid major, and erector spinae over the
transverse process which is hyperechoic. A 5cm 22-gauge stimuplex block needle was inserted
in-plane in a cephalo-caudad direction and the needle pointed to the tip of the transverse process,
piercing the erector spinae. 1.5mg/kg of 0.2% ropivacaine was administered in this position after
positive needle tip confirmation and negative aspiration of blood. The process was repeated on
the contralateral side for a cumulative dose of 3mg/kg ropivacaine. Anesthesia was maintained
with sevoflurane 0.9-2% in 50% oxygen in air mixture and supplemental boluses of 0.1mg/kg of
atracurium, with hemodynamics maintained within 20% of baseline. The patient underwent
sternotomy, heparinization, surgical correction, and then weaned off bypass followed by
protamine administration and transferred to the ICU after procedural completion.
To assess pain postoperatively, Kaushal et al. used a Modified Objective Pain Score
(MOPS) at hours 0,1,2,4,6,8, 10 and, 12 post-extubation. Both groups received acetaminophen
15mg/kg IV every 8 hours. If the MOPS score was greater than 4 at rest, fentanyl 0.5-1mcg/kg
was administered IV as rescue analgesia. MOPS at 0,1,2,4,6,8,10, and 12 hours post-extubation
were the primary endpoints. The secondary endpoint of this study viewed intraoperative fentanyl
requirements, postoperative cumulative fentanyl requirement up to 12 hours, Ramsey sedation
score, ICU stays, and the incidence of adverse events.
The MOPS scores for group B were significantly lower than group C until 10 hours postextubation in comparison to group C with no significance in MOPS at the 12th hour. The
intraoperative fentanyl requirements and extubation time were comparable in both groups. All
the children in group C required postoperative rescue fentanyl, whereas rescue was required in
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28 children in group B. Postoperative fentanyl administration in group B (1.08 +/- 0.91mcg/kg)
was significantly less that than in group C (5.52 +/- 3.27 mcg/kg) (p <0.0001). The time duration
to the first rescue analgesic dose Postoperative vomiting was noted in 5 children in group B and
8 children in group C, 2 children in group B and 3 children in group C developed temperatures
up to 38.7˚C, which subsided within 6 hours. No complications were found from the ESPB
technique and LA administration. The author describes the physiology of the ESPB and how it
anesthetizes the dorsal and ventral rami of the spinal nerve roots leading to profound analgesia of
the ipsilateral hemithorax, where LA then spreads in a craniocaudal throughout the erector spinae
fascia. Thus, allowing the single-shot ESPB to cover multiple dermatomes.
Kaushal et al. list the sample size as being a limitation to the study and mentioned that
although pain scores were recorded, the inability to assess dermatomal sensory blockade
considering the age of subjects posed an impediment to the successful establishment of proposed
sternal analgesia. Also, although no adverse events came from the ESPBs, the bilateral nature of
the block poses a risk to LA systemic toxicity. Kaushal et al. concluded with the ability for
ultrasound-guided bilateral ESPB to provide excellent analgesia with a reduced amount of rescue
analgesics after midline sternotomy in pediatric cardiac surgery, and that ESPB promises to be a
simple, effective, and safer regional anesthetic technique considering simple visualization of
sonographic targets and an injection site that is distant from the neuraxis, pleura, and major
vascular structures.
The fourth study in the literature review supporting opioid-sparing anesthesia
implementation in cardiac surgery is by Macaire et al.12 published by the American Society of
Regional Anesthesia and Pain Medicine in 2020. The randomized, double-blind, placebocontrolled trial aims to test the hypothesis that bilateral ESPB with a programmed intermittent
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bolus (PIB) regimen decreases postoperative morphine consumption at 48 hours and improves
analgesia in children undergoing cardiac surgery with midline sternotomy. Macaire et al.
included the findings of the previous article by Kaushal et al., on the decreased need for rescue
analgesics following 12 hours post-extubation, but now adds the component of the PIB to further
decrease opioid consumption up to 48 hours after surgery, with improved postoperative pain
relief when compared with multimodal analgesia management without continuous ESPB. Patient
selection began with information about the study and written informed consent obtained from all
the parents of the children in the study. Initially, 104 children with an ASA status class II were
scheduled for cardiac surgery with midline sternotomy. The exclusion criteria consisted of
family refusal, a preoperative ejection fraction less than 35%, ventricular
arrhythmia/dysrhythmia, preoperative inotropic support, redo or emergency surgical procedures,
and allergies to amide-type LAs. 47 patients were not eligible and were excluded from the study.
of the 47, eight did not meet inclusion criteria, 11 parents declined the study, and 28 were
excluded for organizational problems. Of the 57 patients included in the study, 3 were excluded
due to the cancellation of surgery.
The patients were enrolled by a physician blinded to the study and randomized into two
groups using a computer-generated random number table. Group 1 patients received an induction
single-shot bilateral ESPB with 0.1%/0.2% ropivacaine followed by a PIB regimen for bilateral
ESPB with saline for 48 hours. The randomly generated patients that were assigned group 2
received an induction single-shot bilateral ESPB with 0.1%/0.2% ropivacaine followed by a PIB
regimen for bilateral ESPB with 0.1%/0.2% ropivacaine for 48 hours. Both groups received
intravenous acetaminophen 15mg/kg every six hours and ibuprofen 10mg/kg every 12 hours as a
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multimodal analgesic approach. Breakthrough and moderate to severe pain control were
managed with rescue intravenous morphine at 30mcg/kg/hour when necessary.
Midazolam 0.25mg/kg was administered two hours before the procedure. Standard
monitoring for cardiac surgery was applied including arterial line and central venous catheter
placement, and appropriate antibiotic dosing. Induction of anesthesia began with propofol
2mg/kg, sufentanil at 0.5-1mcg/kg, and rocuronium at 0.6mg/kg to facilitate endotracheal
intubation. Anesthesia was maintained with sevoflurane (1-2%) in 50% oxygen in air mixture,
rocuronium at 0.4-0.6mg/kg/hr, and sufentanil at 0.1-0.4 mcg/kg/hour titrated to vitals within
20% of baseline. The ESPB was completed with the patient in the right lateral decubitus position
under aseptic conditions. The ultrasound probe was placed in a longitudinal orientation over T3
or T4 transverse process. After identification of structures, a 50mm 20-gauge Tuohy needle was
advanced in-plane, and a 24-gauge epidural catheter was inserted in a cephalo-caudad direction.
The catheter tip location was confirmed by hydro location with 0.5mL of dextrose 5% indicating
a solution spread in the fascial plane between the transverse process and erector spinae muscle.
The catheters were secured with transparent dressings. In children under 1 year, a bolus of
0.25mg/kg/ side of ropivacaine 0.1% was injected as an initial bolus. In children >1year an initial
bolus of 0.50mg/kg/side of ropivacaine 0.2% was injected. The procedure was repeated on the
contralateral side. A maximum cumulative initial bolus of 6mL (6–12mg) per side was allowed.
The surgical procedure continued as usual with sternotomy, heparinization, surgical repair, and
then weaning off bypass and protamine administration. The patients were then transferred to the
pediatric ICU.
The ESPB catheters were connected to a pump to deliver the PIB. The children in group
1 received 0.5mL/kg/side PIB of saline every 6 hours, with a maximum volume of 6mL/side.
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The patients in group 2 received 0.5mL/kg/side PIB of ropivacaine 0.1%/0.2% every 6 hours into
the ESPB catheters, with a maximum volume of 6mL/side. The bolus on the second catheter was
delayed by one hour in both groups. All patients received IV paracetamol 15mg/kg every 6 hours
and ibuprofen 10mg/kg every 12 hours. Postoperative pain scores were assessed using the
COMFORT-B score and the FLACC scale for these patients. Moderate to severe pain was
determined by a COMFORT-B score of greater than 17, or a FLACC value greater than 3. If
pain persisted despite multimodal analgesia, rescue analgesia with IV morphine 30mcg/kg/hour
was administered. Inspection on the catheter site took place twice a day to ensure no redness
around the site.
Macaire et al. provided the results for the study with validated figures and data
representative of the study methods. In group 1 with the saline infusing ESPB catheters, the total
morphine consumption at 48 hours was 512+/- 560mcg/kg. In group 2 with the PIB of
ropivacaine, the 48-hour morphine consumption was 120+/- 320mcg/kg; with a P-value of 0.03.
41% of patients in group 1 required rescue analgesia with IV morphine compared to 14% of
patients requiring rescue analgesia in group 2. Patients in group 2 also demonstrated lower
FLACC scale values at 20 hours and 24 hours compared to the saline group, with no significant
differences at other times. No differences between the two groups were observed for extubation
time, time to drain removal, time to first active mobilization, and length of ICU and hospital
stays. Vomiting episodes were also reduced in group 2 compared to group 1 with saline. The
author mentions the inadvertent removal of the catheters occurred in 13 percent of patients in
group 1, and 15 percent of patients in group 2.
Macaire et al. concluded by stating that the use of bilateral ESPB with an automated
intermittent bolus of ropivacaine significantly reduced postoperative morphine consumption at
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48 hours, reduced postoperative pain values at 20 and 24 hours, and specifically after extubation
and drain removal, with no effect on time to extubation and length of ICU/hospital stay. The use
of bilateral ESPB with PIB also reduced the incidence of vomiting and serves as a useful
technique for opioid-sparing postoperative analgesic regimens after pediatric cardiac surgery.
The author also mentions that although regional anesthesia is gaining popularity in pediatric
cardiac surgery, only approximately 43% of pediatric centers are using these techniques, opting
for the use of multi-modal or fast-track approaches without regional anesthesia. From prior
studies not using regional techniques, the median equivalent morphine dosages are 102mcg/kg in
post-anesthesia care units, approximately 460mcg/kg in the first 12 postoperative hours, and
from 400-approximately 630mcg/kg at 24 hours, compared to the 120mcg/kg average of this
study. The author hints that the use of IV opioids as rescue analgesics cannot fully provide pain
relief. Macaire et al. critiqued the sample size of the study as the first limitation. Another
limitation to the study is that the pediatric patients were not enrolled in a fast-track anesthesia
with an on-table extubation program, which could be the best situation for the use of bilateral
ESPB analgesia, and thirdly, the study did not assess the dermatomal sensory blockade in the
participants.
The fifth study in the literature review is titled Enhanced Recovery and Early Extubation
after Pediatric Cardiac Surgery Using Single-Dose Intravenous Methadone by Iguidbashian et
al.17 published by Wolters Kluwer in the 2020 Annals of Cardiac Anaesthesia journal. The
retrospective study aims to assess the efficacy and safety of a multimodal pain regimen centered
around a single-dose intraoperative IV methadone in pediatric cardiac surgical patients. The
retrospective case study analyzed children greater than six months of age undergoing cardiac
surgery in which a fast-track method to facilitate extubation and ERAS was implemented with a
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single anesthesiologist and a single surgeon where the likelihood of postoperative hemodynamic
instability, ongoing coagulopathy, or bleeding was anticipated to be low. The multi-modal
analgesic regimen consisted of methadone 0.2-0.3mg/kg IV bolus before incision, ketamine
0.5mg/kg IV bolus prior to incision and, lidocaine 1mg/kg IV bolus prior to incision. Anesthesia
was induced with sevoflurane and or propofol and maintained with sevoflurane 1-1.2 the
minimum alveolar concentration (MAC). Muscle relaxation was induced with rocuronium prior
to incision. Dexamethasone (0.15mg/kg) was given prior to incision, and ondansetron
(0.1mg/kg) was given prior to emergence as prophylaxis for postoperative nausea and vomiting.
A continuous infusion of ketamine at 0.25mg/kg/hr and lidocaine at 1.5mg/kg/hr was started
from incision to skin closure. Before emergence a 15mg/kg IV bolus of acetaminophen was
given and regional anesthesia using a parasternal block was performed with Ropivacaine 0.2%.
Postoperative supplemental analgesics consisted of scheduled oral acetaminophen and IV
ketorolac. If needed, breakthrough analgesia with IV fentanyl and IV morphine, and oral
oxycodone were available.
A total of 24 children were included in the study. 22 patients had procedures done on
CPB of which 11 involved a re-entry sternotomy. The youngest patient was 8 months old and
weighed 6.2kg. Four patients had single-ventricle pathology. Surgeries performed included six
aortic valve replacements, four Fontan procedures, three repairs of atrial septal defects, two
pulmonary valve replacements, amongst other cardiac procedures outlined in article. 23 children
were extubated in the OR and transported to the pediatric ICU. Postoperative vital signs were
obtained within 30 minutes of arrival. No child required intraoperative supplemental opioid
administration. Iguidbashian et al. reported the first respiratory rate in the ICU to be 14, with an
arterial partial pressure of carbon dioxide to be 51. One child required non-invasive ventilation
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for approximately 60 min due to moderate hypoxemia and then transitioned to a 2L nasal
cannula. The median time to first supplemental opioid administration was 5.1 hours, the median
morphine equivalent dosing in the first 24 hours was 0.2mg/kg, and a median of 0.42mg/kg at 72
hours postoperatively. The author interprets the supplemental opioid requirements as modest and
suggests methadone is accomplishing the bulk of the basal pain control in the initial
postoperative period.
The article proceeds to disclose the limitations of the study and system flaws. The study’s
sample size is small, is not randomized, and does not have a control group to compare the effects
of methadone. System flaws with extubating the patients in the OR and then going to ICU while
the patient is spontaneously breathing the author mentioned was difficult for the ICU nurses.
Larger, randomized controlled studies are needed to validate the use of methadone in cardiac
surgery.
The sixth article for review is Medicine journals’ 2020 article by Ming et al.21 This
randomized controlled trial studied the effect of dexmedetomidine on perioperative
hemodynamics and organ protection in children with congenital heart disease undergoing openheart cardiac surgery. Ming et al. quoted previous literature that supported dexmedetomidine’s
anesthetic sparing effects, the attenuated release of inflammatory mediators and neuroendocrine
hormones, and the potential to abate ischemic brain damage. The study is aimed at evaluating the
efficacy of different dosages of dexmedetomidine on hemodynamics and organ protection
including heart, brain, and kidney in CHD children.
Participants chosen were children aged 1-6 with CHD, scheduled for repair of
atrioventricular septal defect (ASVD) under CPB, with an ASA class II/III. Participants that
were excluded were those with severe malnutrition and cyanosis, were born premature, and had

Page 40 of 91

41
low birth weight. Also, patients with prior cardiac surgery, with pulmonary hypertension, or
those allergic to opioids were excluded, and patients with a history of cerebral palsy, severe renal
or hepatic disorders were excluded.127 participants were assessed, 37 were excluded from the
study. The remaining 90 children were randomly allocated to group C, group D1, and group D2.
Group C received 0.9% saline at 0.2mcg/kg/hr, group D1 received dexmedetomidine at
0.2mcg/kg/hr, and group D2 received dexmedetomidine at a rate of 0.4mcg/kg/hr.
The anesthesia protocol consisted of midazolam (0.1mg/kg), fentanyl (3-8mcg/kg),
propofol (1-3mg/kg), and vecuronium (0.1mg/kg) followed by endotracheal intubation, and
maintenance with sevoflurane 1% From the start of anesthesia, dexmedetomidine was infused
continuously for groups D1 and D2 and their subsequent rates, and saline was continuously
infused for group C. After sternotomy and heparinization, the patients were placed on CPB and
cooled to 30-34 degrees. After completion, the heparin was reversed at a 1:1 dosage with
protamine.
Hemodynamic data included MAP and heart rate, levels of lactic acid in blood samples,
and levels of C-reactive protein which were measured at timed intervals starting from before
induction (T0) to 30 minutes after extubation (T7). For the detection of organ injury markers,
arterial (radial artery) and venous blood (internal jugular vein) samples were obtained before
surgery, 30 min after CPB, at the end of CPB, after the surgery, and 24 hours post-procedure.
The arterial-venous oxygen concentration difference and cerebral oxygen extraction ratio were
calculated using Fick’s formula. 3-5mLs of venous blood were removed before and at the end of
the surgery, and 6-, 24-, and 48-hours post-procedure followed by centrifugation at room
temperature at 4000 revolutions/min for 10 minutes. The supernatant was isolated and stored at 80˚C and allowed for detection and interpretation of serum myocardial injury markers, brain
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injury markers, and kidney injury markers via an enzyme-linked immunosorbent assay. BUN and
serum creatinine were also analyzed for the incidence of acute kidney injury. Secondary
outcomes that were measured included extubation times, emergence agitation, postoperative pain
scores, and adverse events. The results of the study demonstrated that compared with group C,
group D1 and D2 had lower hemodynamic parameters, lower myocardial and brain injury
indicators, and quicker tracheal extubation times. There was no significant difference in the
incidence of kidney injury in all three groups. Nausea, vomiting, agitation, and FLACC scale in
groups D1 and D2 were lower than those in group C. The intraoperative fentanyl requirement
was notably lower in the D2 group. After tracheal extubation, 18 children in group C were given
an IV drip of tramadol for analgesia, 13 in group D1, and 10 in group D2.
Ming et al. concluded that in children with CHD undergoing CPB, dexmedetomidine
reduces the dosage of other anesthetic drugs, inhibited inflammatory stress response, and
maintains perioperative hemodynamic stability. Dexmedetomidine also downregulates the
expression of myocardial and brain injury markers, lowers the incidence of tachycardia, nausea,
vomiting, and moderate agitation, and shortens tracheal extubation times. Dexmedetomidine at a
rate of 0.4mcg/kg/hr can further decrease the dosage of fentanyl and dopamine compared with
dexmedetomidine at 0.2mcg/kg/hr. Ming et al. deemed dexmedetomidine at a rate of
0.4mcg/kg/hr a clinically safe and effective anesthesia adjuvant for pediatric open-heart surgery.

Discussion
This 2019 study by Guinot et al. is the first of its kind to specifically focus on the
feasibility of OFA in cardiac surgery undergoing CPB. The findings by Guinot et al. supporting
the use of OFA, or a minimal opioid approach in cardiac surgery became the basis for further
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studies such as that by Aguerreche et al. The retrospective study by Aguerreche et al.
demonstrates the potential for dexmedetomidine as the foundation in an opioid-sparing
anesthesia approach to cardiac surgery. Dexmedetomidine offered numerous benefits in the
cardiac patient having cardiac surgery and compounded to the information presented in the
article by Guinot et al., which focused on the use of other non-opioid adjuvants without
dexmedetomidine (due to unavailability) in open-heart cardiac surgery.
Multiple articles supported the use of regional anesthesia in the preserving opioid usage,
however the ESPB offered multiple advantages, as demonstrated in the study by Kaushal et al.
The article was chosen for literature review as it demonstrated the ability of the ESPB to have a
major opioid-sparing effect in cardiac surgery. The bilateral ESPB as a newer regional technique
in cardiac surgery proved to reduced opioid consumption, demonstrated efficacy, was safe, and
simple to implement for the anesthesia provider. The following article by Macaire et al. provided
further insight into the opioid-sparing effects of bilateral ESPB in cardiac surgery. Where the
article by Kaushal et al. demonstrated the analgesic benefits to using the ESPB in pediatric
cardiac surgery, Macaire et al. found that the addition of PIBs of ropivacaine can further prolong
analgesia and diminish post-operative morphine consumption beyond 12 hours (Kaushal et al.) to
48 hours without causing LA systemic toxicity in pediatric cardiac patients undergoing openheart surgery via midline sternotomy.
The article by Iguidbashian et al. is one of the first to propose the use of IV methadone as
the cornerstone of an analgesic regimen in pediatric cardiac surgery. Iguidbashian et al. focused
on the use of methadone in the pediatric cardiac population versus the use of more traditional
approaches using short-acting analgesics and explains that in traditional methods, pain levels
tend to wax and wane in relation to the varying plasma drug levels. Iguidbashian et al.
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hypothesized that methadone due to its long duration of action of approximately 24-36 hours
may provide steadier, basal pain control during the period of greatest surgical pain. Alternatively,
methadone also displays antagonizing effects on the N-methyl-D-aspartate (NMDA) receptor,
may prevent the hyperalgesia related to chronic pain syndrome, and has fewer respiratory side
effects19 when compared to other rescue analgesics such as fentanyl, morphine. Also, of the
articles reviewed for inclusion of the literature review, the intraoperative approach to this study
is amongst the most opioid sparing by design with the inclusion of dexamethasone, ketamine,
lidocaine, acetaminophen, ketorolac, and regional anesthesia, with a focus in OR on-table
extubation.
Having adequate information to solidify an implementation guide based on
dexmedetomidine, regional anesthesia with ESPB, and methadone as an alternative to short
acting opioids, the study by Ming et al. solidifies the usage of a dexmedetomidine based opioidsparing anesthesia in cardiac surgery with the findings that dexmedetomidine at a rate of
0.4mcg/kg/hr is clinically safe and diminishes organ injuries in children undergoing open-heart
surgery. Ming et al. explained the strong physiological stress response that is seen during openheart surgery. For instance, when the ascending aorta is blocked during CPB it significantly
diminishes normal blood perfusion to various organs of the body. Meanwhile, the blood in CPB
is directly exposed to extracorporeal circulation pipeline and oxygenator, resulting in the
generation of numerous inflammatory cytokines and cascade release, which can precipitate
systemic inflammatory response syndromes. Hyperglycemia and hyperlacticacidemia are caused
by this strong stress response, and hemodynamic instability during surgery can cause ischemia
and reperfusion injuries. These hemodynamic and physiologic changes can cause organ damage
to the heart, lung, brain, and kidneys.
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As opioid-sparing cardiac surgery gains popularity and interest, there will be more
randomized controlled trials about opioid-sparing anesthesia in cardiac surgery. Sorting through
search findings in the CINHAL database, numerous case reports validated the methods described
above. One example is the Elsevier published case report in the Journal of Cardiothoracic and
Vascular Anesthesia on opioid-free ultra-fast-track CABG surgery using ESPB catheters.11 The
case report describes a 74-year-old male undergoing CABG surgery with similar anesthetic
approaches to those described by Guinot et al., Aguerreche et al., and Iguidbashian et al. with the
use of versed, ketamine, propofol, ketamine, and magnesium for the induction of anesthesia,
followed by bilateral ESPB with ropivacaine, acetaminophen IV and on table extubation. In this
case report the patient received only 10 mg of oral oxycodone for postoperative pain. A recent
2021 case report from Turkey by the Anesthesia and Pain Management Journal11, describes a
similar anesthetic regimen that mainly excluded the use of opioids from the preoperative phase to
postoperative in three cardiac patients. Two patients were undergoing CABG surgery and the
third patient underwent mitral valve repair, all which were successful under CPB. The ESPB
were bilateral with catheters left in place for postoperative ropivacaine infusions. This case
report used tramadol as a rescue analgesic versus morphine or fentanyl which was only used in
one of the three patients. Unfortunately, these are only case reports and thus were not included in
the literature review and are thus a limitation in this review. Further clinical studies are needed to
validate the results; however, these two case reports encompass the use of opioid-sparing
techniques throughout the perioperative course and includes the ESPB with the epidural catheters
for programmed infusions of ropivacaine. The limited amount of research available on opioidsparing anesthesia in open-heart cardiac surgery is inherently a limitation to this review. Of the
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research available, the consensus is that larger, randomized clinical trials are needed to validate
the findings.

Conclusion
Future research on opioid-sparing anesthesia in cardiac surgery with CPB will validate
the results presented. The term “opioid-sparing” is subject to multiple interpretations as noted in
the literature review. These recommendations serve as a guide and are vary depending on patient
history, disease physiology, and surgical procedure. The educational intervention tool to improve
the knowledge of anesthesia providers in opioid-sparing cardiac surgery will suggest for the use
of short-acting opioids such as fentanyl be minimized to treat breakthrough pain postoperatively,
or for a single-dose of methadone, with a longer duration of action and safer pharmacological
profile be given prior to incision. The educational tool recommends the use of regional
anesthesia to further spare the use of opioids. After the induction of anesthesia, bilateral ESPB
with 0.2% ropivacaine with epidural catheters left in place for PIBs of ropivacaine is
recommended. The intraoperative use of dexmedetomidine IV infusion at a rate of 0.4mcg/kg/hr
is recommended during cardiac surgery. Ketamine per the literature reviewed may be used
intraoperatively (IV infusion) or postoperatively (IV boluses). Postoperative redosing of
ropivacaine 0.2% via PIBs is recommended to help mitigate pain transmission up to 48 hours. IV
acetaminophen around the clock is recommended postoperatively.

Purpose/PICO Clinical Questions/Objectives
PICO Question or Purpose
Population (P): Anesthesia Providers
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Intervention (I): Opioid-Sparing Anesthesia for Cardiac Surgery education tool
Comparison (C): None
Outcomes (O): Improved provider knowledge of anesthesia techniques that minimize
opioid usage in cardiac surgery.
Primary DNP Project Goal
Opioid use and abuse along with addiction have become a significant issue for the last
decade. In fact, opioid overdose is now one of the leading causes of unintentional death in the
United States, surpassing motor vehicle accidents.4 Most surgical patients often receive some
form of opioid narcotic throughout the perioperative period and then postoperatively. The reason
being, that opioids are potent with a rapid onset of action without an analgesic ceiling,4 but with
the increasing use of opioids, it has become a realization that its benefits might be overshadowed
by the potential downsides.5 Researchers have shown that opioid-naïve patients often can
become dependent on narcotic administration after surgery. The anesthesia provider plays a
paramount role in the primary stage of the patient’s exposure to such potent drugs, and therefore
can be a leading agitator to these key issues.
Cardiovascular disease is now the leading cause of global death with an estimated
seventeen million deaths per year, and the number is set to increase to twenty-three million by
the year 2030.8 Cardiovascular surgery typically involves the coronary arteries, heart valves, or
other cardiac structures that may need to be accessed by the surgeon for repair. Cardiac surgery
is associated with moderate to severe pain from median sternotomy, chest tube insertion, and
costovertebral joint distention.2,11 Vascular access sites and saphenous graft harvest sites also
cause significant pain. However, ineffective pain control after cardiac surgery can lead to
sympathetic activation, resulting in unstable hemodynamics and increased demand for oxygen2
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Traditionally, high-dose opioid induction and maintenance were considered the gold standard for
cardiac patients in the 1980s. However, that concept came packaged with side effects of
prolonged mechanical ventilation, increased length of stay in the intensive care unit and
hospital2, increasing awareness, and allowing for other methods to be introduced. Although
providers use a multi-modal approach to analgesia with non-opioid adjuvants, intraoperative
opioid usage ultimately varies between patient, procedure, and anesthesia providers.11 Focusing
on the anesthesia provider, the objective of the development of an opioid-sparing anesthesia
guide for cardiac surgery requiring cardiopulmonary bypass is to reexamine traditional practices
and replace them with evidence-based guidelines in order to achieve early postoperative recovery
and mobility while establishing comparable levels of pain control by a significant reduction in
the amount of perioperative opioid administration to reduce the potential for opioid-related
adverse effects, and subsequently improve the current knowledge of anesthesia providers on the
implementation of an opioid-sparing anesthetic approach in cardiac surgeries.

Goals and Outcomes
To guide the development of the goal objectives, the acronym SMART was utilized. SMART
details that the objectives should be specific, measurable, achievable, realistic, and timely.22
These goals will guide the implementation of the quality improvement project.
Specific
Anesthesia providers will receive an educational intervention tool with evidence-based
information for the implementation of an opioid-sparing anesthesia technique in cardiac surgery.
Measurable
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The effectiveness of the opioid-sparing anesthesia technique or protocol in cardiac
surgery will be derived through the analysis of a questionnaire that will be provided to
participants before and after an educational intervention. Outcomes will be measured by
evaluating the variations in the anesthesia providers’ knowledge of opioid-sparing anesthesia and
its role in cardiac surgery, the pharmacological agents and techniques utilized, intraoperative and
postoperative pain management, and indications/contraindications for use, pre, and postintervention. In order to generate reports, Qualtrics® software will be used to create the surveys
and analyze data.
Achievable
Anesthesiologists, Certified Registered Nurse Anesthetists (CRNA), Certified
Anesthesiologist Assistants (CAA) and other anesthesia providers will benefit from the
educational intervention tool on opioid-sparing anesthesia in cardiac surgery.
Realistic
Anesthesia providers will be educated on the new opioid-sparing technique in cardiac
patients undergoing CPB. Clinical informatics will develop an electronic order set for easy
access in fast-track or on-table-extubation candidates.
Timely
The opioid-sparing anesthesia in cardiac surgery implementation guide will be completed
and available to anesthesia providers within a 1-month time frame. The outcome of this initiative
will be as follows: within a 1-month period, anesthesia providers will have access to an
evidence-based opioid-sparing implementation guide for patients who undergo cardiac surgery to
improve postoperative outcomes and optimize patients for extubation and mobilization, while
reducing the perioperative consumption of opioids.
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Program Structure
The development of an opioid-sparing anesthesia pathway in cardiac surgery will require
collaboration amongst anesthesia providers. A comprehensive assessment will be performed via
a pre-test to identify where opportunities exist and the importance, value, and significance the
project will have to all stakeholders.22 The educational module will serve as the educational
intervention for anesthesia providers to learn more about opioid-sparing anesthesia and its role
in open-heart cardiac surgery. Then after the intervention, a post test will be administered to the
anesthesia providers to determine if the intervention was successful. The strength, weakness,
opportunities, and threats analysis assessment tool will be utilized to evaluate the internal and
external characteristics and threats to the program’s development.
Because the project aims to improve anesthesia provider’s knowledge of opioid-sparing
anesthesia techniques when caring for cardiac patients who have undergone cardiac surgery
with CPB, the first step will be to identify a team of expert stakeholders. The expert
stakeholders will guide the development of the opioid-sparing anesthesia protocol and the
anesthesia providers’ educational intervention. The participants will first be provided with a
questionnaire to measure their knowledge of opioid-sparing anesthesia, anesthesia in cardiac
surgery, fast-track and ERAS protocols, and pharmacological agents used in opioid-sparing
anesthesia. Participants will then be provided with an educational course addressing the care of
the cardiac patient with cardiac disease who undergoes cardiac surgery with CPB and the use of
opioid-sparing anesthesia. This course will be provided to anesthesia providers through inservices and huddles. After the intervention, participants will be asked to take a survey that will
analyze the variations in their knowledge before and after the educational course.
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Strengths
Opioid-sparing anesthesia in cardiac surgery has been the recent topic of discussion in
research. Multiple strengths have been identified, one being, the support through literature
demonstrating a benefit in a broad range of patient populations from neonates to pediatric
patients, and from adults to the elderly undergoing open-heart surgery requiring CPB.
Furthermore, there is strength in the feasibility of clinical application in comparison to
traditional methods and the subsequent reduction in opioid requirements postoperatively. Apart
from the reduction of opioids, positive patient outcomes are prevalent with opioid-sparing
anesthesia for cardiac surgery and are associated with quicker extubation times, a decreased
need for post-operative non-invasive ventilation, a decreased incidence of postoperative
delirium, intraoperative organ protection, and the facilitation of on-table extubation.16,17,21 Also,
opioid-sparing anesthesia in cardiac surgery is not limited to open-heart surgery requiring CPB
and has been recorded to be beneficial in other cardiac cases such as in transfemoral
transcatheter aortic valve implantations.23 As most of these high-acuity cardiac surgery cases are
regularly seen at the current clinical site, the clinical site thus serves as a major strength for this
project and adoptions that may come from it.
Another strength in opioid-sparing anesthesia in cardiac surgery is that the goal of
sparing opioids can be met by the implementation of one, or some, or all, of the opioid-sparing
anesthetic strategies. For instance, the anesthesia provider can choose to “spare” the use of
opioids by inserting bilateral epidural catheters and giving a bolus and infusion of ropivacaine
via an erector spinae plane block (ESPB) and perhaps not start a dexmedetomidine infusion.
Because the goal of reducing opioids would be met with either method, there is strength in the
variety available to the anesthesia provider. Lastly, a strength of an opioid-sparing anesthesia
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approach to cardiac surgery lies in its potential to guide future clinical application in other
subspecialties as more research becomes available. Adhering to the nationwide call to combat
the opioid crisis, there is insurmountable strength in the ability for opioid sparing techniques to
help save lives, decrease opioid-dependence in opioid-naïve patients, and help purvey the
shifting of the current paradigm in cardiac surgery.

Weakness
As defined by Moran et al.22, the plan’s weaknesses are any internal issues that may be
damaging to the program. There are weaknesses to implementing an opioid-sparing anesthetic
technique in cardiac surgery requiring CPB such as the requirement for the anesthesia provider to
be proficient with multiple pharmacological agents as well as regional anesthesia. This may be
seen as a weakness by stakeholders due to the additional risk involved with adding more drugs to
achieve analgesia during CPB. For instance, a patient cannot have an allergy to amide anesthetics
to maximize the benefits of opioid-sparing anesthetic and analgesic effects if an ESPB is to be
done. This is also true for the additional pharmacological agents involved in an opioid-sparing
approach to anesthesia in cardiac surgery on CPB. Therefore, hindering the ability to standardize
an opioid-sparing technique in cardiac surgery requiring CPB. Another weakness to the
implementation of opioid-sparing anesthesia in cardiac surgery requiring CPB is the lack of
research available, and the variability amongst the methods of anesthesia management for
induction, maintenance, and post-operative phases, and certain biases present in the articles that
are present. This variability in anesthesia care for the patient is seen in the current clinical site,
with some providers being open to the idea and other providers refusing its use in cardiac surgery
due to the way things have been done before. Standardization is needed to validate the results of
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an inclusive opioid-sparing anesthesia technique for cardiac surgery with the use of multi-modal
non-opioid adjuvants for intraoperative management such as dexmedetomidine, ketamine,
dexamethasone, magnesium, propofol, gabapentin, non-steroidal anti-inflammatory agents,
regional anesthesia with the ESPB with bolus and continuous infusions of ropivacaine, and the
consideration for methadone over the use of short-term opioids.
Opportunities
The implementation of an opioid-sparing anesthetic guide for cardiac surgery requiring
CPB can provide opportunities for other anesthesia team members to learn and become involved
in the adoption of opioid-sparing open-heart surgery. Learning about this process will also
provide an opportunity for other anesthesia providers to learn about the power of the different
non-opioid adjuvants and utilize them in their practice. For example, the organ protecting effects
of dexmedetomidine as described by Ming et al.21, is not only suitable for open-heart surgery but
could provide the opportunity to be used in other surgeries where organ protection is desired.
Also, an opportunity for the use of opioid-sparing anesthesia in cardiac surgery may be present in
hospital facilities where the culture is to embrace and implement evidence-based practices, these
facilities could recruit participants looking for the latest advancements in care. An example
where these observations can translate and transition into patient care has been seen in the
current clinical site, where the culture is one that is embracing of change. The current clinical site
provides an opportunity for this project to become embraced.
There is also a large amount of opportunity in the application of opioid-sparing
anesthesia in cardiac patients who are at high-risk for opioid dependence or have suffered
adverse reactions to opiates in the past. With the use of opioid-sparing anesthesia in this patient
population, opioid-related adverse effects are minimized without jeopardizing quality care or
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pain control. Also, opioid-sparing anesthesia in cardiac surgery with the use of regional
anesthesia can help improve ERAS protocols into “fast-track”, or “ultra-fast track” (to
extubation) methods in select candidates in efforts to extubate post-open-heart patients on the
table.17,24
Threats
Factors that may potentially harm the process or interfere with the program’s ability to
achieve its objectives must be evaluated.22 The largest threat to the implementation of opioidsparing anesthesia for open-heart cardiac surgery requiring CPB is the resistance to change from
the anesthesia providers, the cardiac surgeons, and the institutions/facilities where the operations
are performed. The institute of medicine reported that the average time lag from discovery to
knowledge to its application in practice is 17 years.9 Opioids such as fentanyl are still considered
the standard analgesic agent in cardiac surgery, because of this notion, providers might not be
accepting of potential changes to their practice. Older practicing anesthesia providers may not
feel comfortable with the thought of a patient having open-heart cardiac surgery, on CPB, and
the restriction of opioids for pain. These providers have been trained to do things a certain way
with effectiveness, and to abandon what has worked to implement a new strategy will be met
with resistance. It is expected that this level of resistance will be seen when demonstrating the
current literature at the current clinical site. However, White et al. explains that a resultant
decline in best care knowledge for patient care occurs due to the rate of growth of new
knowledge and the delays of implementing that new knowledge. Because there is so much
information for the clinician to read and evaluate for its use in practice, it is widely recognized
that the knowledge of best care has a negative correlation with the year of graduation.9
Organizational factors

Page 54 of 91

55
The implementation of the opioid-sparing anesthesia for cardiac surgery protocol will be
conducted within a collaborative team approach amongst anesthesia providers. We will first
determine the steps needed to develop the opioid-sparing anesthesia for cardiac surgery
protocol. A flowchart will be formed to represent the visualization of the process steps. Data
can be analyzed and compared with the goals and expectations devised during the planning
phase through chart reviews that assess the total opioid consumption, individual patient
outcomes, and length of stay pre, and post-implementation of the opioid-sparing anesthesia
protocol for cardiac surgery. In the evaluation phase, the anesthesia providers will be
interviewed to obtain their input on the educational tool and the overall effectiveness evaluated
by the difference in knowledge obtained by the anesthesia provider through a pre- and posteducational intervention tool exam.

Conceptual Underpinning and Theoretical Framework of the Project
Pertinent to the implementation of an opioid-sparing anesthesia protocol in cardiac
surgery for open-heart procedures, a translation theory will be used to guide the process.
Translation theories focus on the interrelationships and complex organizational dimensions that
are relevant to the translation and research of new knowledge into practice. Rogers’s Diffusion
of Innovations Theory is useful in understanding individuals’ reactions to change. Change in this
theory occurs when innovation is introduced and is perceived as new by an individual. Opioidsparing anesthesia in cardiac surgery on CPB will be perceived by many as new, and hence,
would serve as a catalyst for translating innovation towards change. The second part of the
theory describes a five-step innovation-decision process in which the individual transitions from
the knowledge phase, which begins when the individual becomes aware of the innovation, to the
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implementation and confirmation phase where the individual implements the innovation and then
decides on whether to continue the use of the innovation or not.9 The model ties in with the
interventional educational tool to be presented to anesthesia providers in which the information
is made available, and tested on the retention of new knowledge, and then left to the anesthesia
provider to adopt, implement, and continue to use upon favorable results.
Methodology
Setting and Participants
This project took place at Memorial Regional Hospital in the surgical department where
there were many scheduled and emergent surgical procedures, including elective cardiac, and
emergent cardiac surgeries. There are approximately 30 anesthesia providers currently providing
care at this practice and they vary from anesthesiologists, to AAs, and CRNAs. This practice is
in Hollywood, FL, and the anesthesia providers themselves, as well as all the population they
serve, are of diverse backgrounds.
Description of Approach and Project Procedures
The DNP project intervention began with inviting the anesthesia providers of this practice
to participate in the QI project. The results of the pretest/posttest design were used to measure
self-reported knowledge on opioid-sparing anesthesia in cardiac surgery. The data collected
before the educational intervention includes demographic information, years of practice, and
history of previous cardiac surgery experience in years. The education program contained the
information regarding implementation and indication for an opioid-sparing approach, its
pharmacological techniques, regional anesthesia approaches, and alternatives to current opioidbased practice. Throughout the training, providers were invited to speak openly about their own
experiences with opioid-sparing anesthesia, opioid-related adverse events, and their thoughts for
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use in both their professional and personal capacities. The training lasted approximately 60
minutes, and after the educational segment participants completed a post-test survey.
Protection of Human Subjects
All anesthesia providers from the previously described practice were invited to participate
via email. Florida International University Institutional Review Board (IRB) approval was
obtained for the project with minimal risk. Participants consented via Qualtrics, with the
opportunity and right to withdraw their consent at any time. Benefits of participation included
the improvement of knowledge in cultural competency, minority cultures, and self-reflection on
their own culture and how it affects their care. No identifiable data was collected during this
project, however, due to the size of the sample participants were identified through indirect
identifiers. The data collected was stored in a password-protected online database only accessible
to the primary investigator.
Data Collection
Demographic data collected included gender, race, ethnicity, and education. Additionally,
participants provided an approximation of the number of years they have been practicing and
whether they have previously used opioid-sparing or opioid-free anesthesia during cardiac
surgery. Data collected consisted of a pre-test that gauged the anesthesia providers' knowledge of
opioid-sparing anesthesia in cardiac surgery, and the post-test determined the knowledge
acquired following the educational intervention.
Data Management and Analysis Plan
Data collected was stored in an electronic database. Only the primary investigator had the
password to this database. No direct identifiers were collected in this investigation and all results
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were reported in aggregate. Questionnaires were collected and scored; the means of the total
scores and sub-scores were compared before and after the intervention.

Results
Demographics
The demographics of the participants surveyed are represented below.
Consent to participate
Answer

%

Count

Consent to Participate

100.00%

7

Withdraw from survey

0.00%

0

Total

100.00%

7

Gender
Answer

%

Count

Male

42.86%

3

Female

57.14%

4

Total

100%

7

Ethnicity
Answer

%

Count

Hispanic

28.57%

2

Other

71.43%

5

Total

100%

7

Level of Education
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Answer

%

Count

Masters

28.57%

2

Doctorate

57.14%

4

JD or MD

14.29%

1

Total

100%

7

Years as an anesthesia provider
Answer

%

Count

0-5

71.4%

5

5-10

0.00%

0

10-15

0.00%

0

Greater than 15

28.6%

2

Total

100.00%

7

A total of 42 invitations were distributed via email to anesthesia providers to participate
in the pre-and post-test educational intervention. Seven participants consented to participate, no
surveys were left incomplete, totaling seven participants for the quality improvement project.
The demographics of those who participated are represented by the following: male (n = 3,
42.9%), female (n = 4, 57.1%), Hispanic (n = 2, 28.6%), other (n=5, 71.4%). Six participants
were certified registered nurse anesthetists (n = 6), with either a Master’s degree (n = 2, 28.6%),
or Doctorate (n = 4, 57.1%), and less than 5 years experience (n = 5, 71.4%) or 15 or more years
experience (n = 1, 14.3%) as an anesthesia provider. One participant was an MD (n=1, 14.3%)
with 15 or more years experience (n = 1,14.3%, group total n=2, 28.6%)
Pre-Test Knowledge of Opioid-Sparing Anesthesia for Cardiac Surgery
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The pre-test consisted of 12 questions that assessed the current knowledge of opioidsparing anesthesia in cardiac surgery. Five (n = 5, 71.4%) of the seven participants correctly
answered that respiratory depression was the most common opioid-related adverse complication.
The same number of participants also successfully historically associated cardiac surgery with
high-opioid inductions. None of the seven participants were able to identify the percentage of
opioid-naïve patients that go on to become chronic users. Six (n = 6, 85.7%) participants
correctly answered and understood the clinical phenomena of hyperalgesia and tolerance,
however only four participants (n=4, 57.1%) correctly answered the definition of hyperalgesia.
One question was marked as invalid, due to a selection error, in which, all participants received
credit for their responses. 1 participant (n=1, 14.3%) successfully answered a question regarding
the timing of pain relief following the erector spinae plane block in the pre-test section.
Post-Test Knowledge of Opioid-Sparing Anesthesia for Cardiac Surgery
After the PowerPoint educational intervention, participants answered a post-intervention
questionnaire consisting of the same questions found in the pre-test. Results assess the
knowledge gained from the educational intervention and are listed below (table 1). All questions
demonstrated an increase in the correct answer when the pre-and post-intervention tests were
compared. The most significant increase in provider knowledge was noted in the response
regarding the percent of opioid naïve patients, where in the pre-test none of the participants
answered correctly and in the post-test six participants answered correctly; demonstrating an
increase in provider knowledge of 85.7%. The same percentage increase in provider knowledge
was seen following the educational PowerPoint regarding the erector spinae plane block.
Table 1
Question

Pre-Test
(n=7)
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Post-Test
(n=7)

Difference
(%)

61
The most common opioid-related adverse
complication is:
Historically cardiac surgeries were assosciated
with:
What percent of opioid-naïve patients who
receive opioids intraoperatively become
chronic opioid users?
A patient had a successful valve replacement
surgery 48 hours ago, this patient received
opioid-based anesthesia, and a total of 600
mcg of fentanyl intraoperatively.
Postoperatively the patient has been requiring
opioids (Fentanyl/Dilaudid) for breakthrough
pain, which are now becoming more frequent.
The anesthesia provider rounds on the patient
and realizes that these may be signs related to:
Dexmedetomidine at 0.4mcg/kg/hr can reduce
the need for postoperative opioid consumption
and has organ protective properties:
The administration of the opioid methadone
causes respiratory depression similar to
morphine or fentanyl:
The lowering of pain thresholds that causes
increases in atypical pain appearing to be
unrelated to the original nociceptive stimulus
is known as?
Regional anesthesia has been shown to be
beneficial in reducing pain and opioid
requirements in cardiac patients. Which are
true of the erector spinae plane block?
Traditional anesthetic management for cardiac
surgery included high-opioid inductions:
According to the literature about erector spinae
plane blocks in pediatric subjects, the addition
of epidural catheters for programmed
intermittent boluses with 0.2% ropivacaine can
decrease postoperative opioid requirements for
up to:
Methadone has properties that act on the
NMDA receptor and avoids hyperalgesia
compared to morphine/fentanyl.
What are some benefits to opioid-sparing
approaches in cardiac surgery?

5

7

+14.3

5

7

+28.6

0

6

+85.7

6

7

+14.3

5

7

+28.6

4

5

+14.3

4

6

+28.6

7

7

0

6

7

+14.3

1

7

+85.7

4

6

+28.6

4

6

+28.6

Summary of Data
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Overall, the results of the educational intervention demonstrated a knowledge increase of
32.2% between the pre-test and post-tests. One question was omitted due to selection error in
both the pre and post test. The most notable increase in provider knowledge was observed in the
question asking to identify the percent of opioid naïve patients that become chronic opioid users.
Also, a notable increase in knowledge was seen in the length of postoperative pain relief
following a bilateral erector spinae plane block with programmed intermittent boluses of
ropivacaine. The following graphs illustrate the differences between the pre-and post-test
answers for each question.

The most common opioid-related adverse
complication is:
8
7
6
5
4
3
2
1
0
Respiratory
depression

Infection
Pre-Test

Tolerance
Post-Test
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Historically, cardiac surgeries were associated
with:
8
7
6
5
4
3
2
1
0
High death rates

High opioid induction Regional Anesthesia

Pre-Test

Conservative opioid
induction and
maintenance

Post-Test

What percent of opioid-naïve patients who receive
opioids intraoperatively become chronic opioid users?
7
6
5
4
3
2
1
0
2%

10%

15%

Pre-Test

Post-Test
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A patient had a successful valve replacement surgery 48 hours
ago, this patient received opioid-based anesthesia, and a total of
600 mcg of fentanyl intraoperatively. Postoperatively the patient
has been requiring opioids (Fentanyl/Dilaudid) for breakthro
8
7
6
5
4
3
2
1
0
Normal postsurgical
pain after open heart
surgery

Clinical phenomena Surgical complications Inability to complete
related to opioids
deep breathing
(antinociceptive
exercises and lack of
tolerance and
mobilization
hyperalgesia)
Pre-Test

Post-Test

Dexmedetomidine at 0.4mcg/kg/hr can reduce
the need for postoperative opioid consumption
and has organ protective properties:
8
7
6
5
4
3
2
1
0

7
5

2
0
Pre-Test

Post-Test
TRUE

FALSE
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The administration of the opioid methadone causes
respiratory depression similar to morphine or fentanyl:
6
5
4
3
2
1
0
Pre-Test

Post-Test
TRUE

FALSE

The lowering of pain thresholds that causes increases in
atypical pain appearing to be unrelated to the original
nociceptive stimulus is known as?
7
6
5
4
3
2
1
0
Upregulation

Hypoalgesia
Pre-Test

Hyperalgesia
Post-Test
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Regional anesthesia has been shown to be beneficial in reducing
pain and opioid requirements in cardiac patients. Which are true
of the erector spinae plane block? (SELECT 2)
8
7
6
5
4
3
2
1
0
Avoids major organs,
Allows for the
Unable to reach the Provides 124 hours of
safe approach
insertion of epidural
sternum/ribs to
pain control
catheters for postprovide significant
operative pain control
pain relief
Pre-Test

Post-Test

Traditional anesthetic management for cardiac
surgery included high-opioid inductions.
8
7
6
5
4
3
2
1
0
Pre-Test

Post-Test
TRUE

FALSE
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According to the literature about erector spinae plane blocks in
pediatric subjects, the addition of epidural catheters for
programmed intermittent boluses with 0.2% ropivacaine can
decrease postoperative opioid requirements for up to:
8
7
6
5
4
3
2
1
0
12 hours

24 hours
Pre-Test

48 hours

72 hours

Post-Test

Methadone has properties that act on the
NMDA receptor and avoids hyperalgesia
compared to morphine/fentanyl.
7
6
5
4
3
2
1
0
Pre-Test

Post-Test
TRUE

FALSE
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What are some benefits to opioid-sparing approaches in cardiac
surgery?
7
6
5
4
3
2
1
0

Pre-Test

Post-Test

Overall increase in provider knowledge from Pre
and Post-test results
100.00%
90.00%
80.00%
70.00%
60.00%
50.00%
40.00%
30.00%
20.00%
10.00%
0.00%
Pre- Test Average

Post-Test Average

% Difference

Limitations
This quality improvement project had several limitations including small sample size.
Forty-two surveys were distributed via email to anesthesia providers at one location, however,
only 7 participants completed the pre-test, educational intervention, and post-test in its entirety.
A larger, more diverse sample size would allow for a more accurate representation of the
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preexisting knowledge of the opioid-sparing anesthetic management for patients undergoing
cardiac surgery. A larger sample size would also validate the effectiveness of the educational
module and intervention. The time frame for the responses is also a limitation, as participants
were given two weeks to complete the survey. Another limitation is sending out the surveys to
only one facility instead of multiple facilities to maximize the amount of participation, instead of
just one community.
Discussion of the Results with Implications for Advanced Nursing Practice
Because anesthesia providers directly maintain anesthesia and analgesia for their patients
during cardiac surgery with the medications of their choosing, whether the provider decides to
administer opioids or consider opioid-sparing alternatives, the result of the anesthesia provider's
decisions lies directly on the patient. Therefore, a valid hypothesis may have many positive
implications. First, it would indicate that a short intervention can be an effective way to reduce
opioid consumption and potential opioid-related adverse events while providing effective
analgesia using newer techniques that are gaining popularity in research. Secondly, a valid
hypothesis would demonstrate that sparing opioids in cardiac surgery can lead to improved
patient outcomes by reducing the incidence of PONV, atrial fibrillation, the need for
postoperative non-invasive ventilation, extubation time, and ICU/Hospital LOS. Also, validity
would ensure that opioid-naïve patients or patients that have struggled with opioid dependence
obtain adequate pain control and lower the total morphine equivalent dosing given
perioperatively, thus giving patients the best chance to avoid opioid dependence or relapse
during major cardiac surgery where surgical pain is significant. This project can have good
implications for health care organizations that wish to offer the latest research and evidencebased practice approaches to their patients, offering an alternative angle to traditional on-pump
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cardiac surgery. Lastly, this project will help guide future research and standardization options
for initiating opioid-sparing anesthesia in cardiac surgery.
Conclusion
With an increasing rate of cardiovascular disease and the subsequent number of cardiac
surgeries, the responsibility of the anesthesia provider for the most up-to-date care concerning
opioid administration in a variety of patients can help optimize postoperative care and outcomes
and can help reduce the number of patients that unfortunately become chronic opioid-users.
Arming providers with multiple techniques to reduce opioid consumption and improve outcomes
can help shift the paradigm of traditional cardiac surgery. The studies provided have their
limitations, mainly being small sample sizes and the need for further research. With time,
advances leading to the adoption of opioid-sparing cardiac approaches to anesthesia care will
flourish.
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Appendix: A IRB Exemption

Office of Research Integrity
Research Compliance, MARC 414

MEMORANDUM
To:

Dr. Charles Buscemi

CC:

Daniel Baez

From:

Elizabeth Juhasz, Ph.D., IRB Coordinator

Date:

March 25, 2022

Protocol Title:

"Improving the knowledge of clinicians of opioid-sparing anesthesia for
cardiac surgery: A quality improvement project "

The Florida International University Office of Research Integrity has reviewed your research study
for the use of human subjects and deemed it Exempt via the Exempt Review process.
IRB Protocol Exemption #:
TOPAZ Reference #:

IRB-22-0100
111350

IRB Exemption Date:

03/25/22

As a requirement of IRB Exemption you are required to:
1) Submit an IRB Exempt Amendment Form for all proposed additions or changes in the
procedures involving human subjects. All additions and changes must be reviewed and
approved prior to implementation.
2) Promptly submit an IRB Exempt Event Report Form for every serious or unusual or
unanticipated adverse event, problems with the rights or welfare of the human subjects, and/or
deviations from the approved protocol.
3) Submit an IRB Exempt Project Completion Report Form when the study is finished or
discontinued.
Special Conditions:

N/A

For further information, you may visit the IRB website at http://research.fiu.edu/irb.

EJ
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Appendix B: QI Project Consent

CONSENT TO PARTICIPATE IN A QUALITY IMPROVEMENT PROJECT
“Improving the Knowledge of Clinicians of Opioid Sparing Anesthesia for Cardiac Surgery: A
Quality Improvement Project.”
PURPOSE OF THE PROJECT
You are being asked to be in a quality improvement project. The goal of this project is to
improve the knowledge of opioid-sparing anesthesia techniques used in open-heart cardiac
surgery, amongst anesthesia providers to reduce perioperative opioid consumption, reduce
adverse effects, and improve patient outcomes.
NUMBER OF PROJECT PARTICIPANTS
If you decide to be in this project, you will be one of thirteen people participating in this research
project.
DURATION OF THE PROJECT
Your participation will require about 90 minutes of your time in the first session and 20 minutes
in the second session that will occur four weeks after your first session.
PROCEDURES
If you agree to be in the project, we will ask you to do the following things:
1. At your first session, you will complete a demographic questionnaire, which includes general
information such as age, gender, position in practice; and a pre-test with the opioid-sparing
anesthesia for cardiac surgery management guideline knowledge
2. In the first session, you will receive a 60-minute educational program about opioid-sparing
anesthesia for cardiac surgery, implementation guide, and literature to support patient
outcomes.
3. Four weeks later, you will be asked to complete the opioid-sparing anesthesia for cardiac
surgery post-test.
RISKS AND/OR DISCOMFORTS
There are no foreseeable risks with you for participating in this project.
BENEFITS
The following benefits may be associated with your participation in this project: An increase in
provider knowledge on opioid-sparing anesthesia for cardiac surgery, which will help you to
better assess anesthetic delivery with guidelines for the implementation of opioid-sparing
anesthesia for cardiac surgery to reduce the risk of opioid-related adverse events. The overall
objective of the program is to increase the quality of healthcare delivery, improving the health
indicator of our patients, and increase patient engagement.
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ALTERNATIVES
There are no known alternatives available to you other than not taking part in this project.
However, if you like to receive the educational material given to the participants in this project, it
will be provided to you at no cost
CONFIDENTIALITY
The records of this project will be kept private and will be protected to the fullest extent provided
by law. If, in any sort of report, we might publish, we will not include any information that will
make it possible to identify you as a participant. Records will be stored securely, and only the
project team will have access to the records.
COMPENSATION & COSTS
There is no cost or payment to you for receiving the health education and/or participating in this
project.
RIGHT TO DECLINE OR WITHDRAW
Your participation in this project is voluntary. You are free to participate in the project or
withdraw your consent at any time during the project. Your withdrawal or lack of participation
will not affect any benefits to which you are otherwise entitled. The investigator reserves the
right to remove you without your consent at such time that they feel it is in the best interest.
RESEARCHER CONTACT INFORMATION
If you have any questions about the purpose, procedures, or any other issues relating to this
research project, you may contact Daniel E. Baez at 786-797-9002, dbaez007@fiu.edu or Dr.
Charles Buscemi at 305-348-4870, cbuscemi@fiu.edu.
IRB CONTACT INFORMATION
If you would like to talk with someone about your rights of being a subject in this project or
about ethical issues with this project, you may contact the FIU Office of Research Integrity by
phone at 305-348-2494 or by email at ori@fiu.edu.
PARTICIPANT AGREEMENT
I have read the information in this consent form and agree to participate in this project. I have
had a chance to ask any questions I have about this project, and they have been answered for me.
I understand that I will be given a copy of this form for my records.
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Appendix C: Recruitment Letter

Recruitment Email for Improving the Knowledge of Clinicians of Opioid Sparing
Anesthesia for Cardiac Surgery: A Quality Improvement Project
Dear Memorial Regional Hospital clinician,
My name is Daniel E. Baez, and I am a student from the Graduate Nurse Anesthesia Department
at Florida International University. I am writing to invite you to participate in my quality
improvement project. The goal of this project is to improve clinicians’ knowledge of opioid
sparing anesthesia or cardiac surgery. You are eligible to take part in this project because you are
a anesthesia provider at Memorial Regional Hospital, and you provide or may provide care to
patients requiring cardiac surgery. I am contacting you with the permission of your department
director and the Chief Nurse Anesthetist at Memorial Regional Hospital.
If you decide to participate in this project, you will be asked to complete and sign a consent form
for participation. You will complete a pre-test questionnaire, which is expected to take
approximately 10-15 minutes. Then, you will then be asked to view an approximately 20-minutelong educational presentation online. After watching the video, you will be asked to complete the
post-test questionnaire, which is expected to take approximately 10-15 minutes. No
compensation will be provided.
Remember, this is completely voluntary. You can choose to be in the study or not. If you'd like
to participate please click on the link provided (link for Qualtrix questionnaire). If you have any
questions about the study, please email or contact me at dbaez007@fiu.edu or 786-797-9002.
Thank you very much.
Sincerely,
Daniel E. Baez
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Appendix D: Letter of Support
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Appendix E: Pre-test/Post-test Questions

Pretest and Posttest Questionnaire:
Improving the Knowledge: Opioid-Sparing Cardiac Surgery
INTRODUCTION
The primary aim of this QI project is to improve the knowledge of anesthesia providers on
opioid-sparing anesthesia for cardiac surgery in order to improve provider education and patient
outcomes in this population.
Please answer the question below to the best of your ability. The questions are either in
multiple choice or true/false format. These questions are meant to measure knowledge and
perceptions on identification, referral, management, and patient education on opioid-sparing
techniques in cardiac surgery.
PERSONAL INFORMATION
1. Gender: Male

Female

Other

Caucasian

African American

2. Age: ______
3. Ethnicity:
Hispanic

Asian Other

4. Position/Title: _________________________________
5. Level of Education: Associates

Bachelors

Other
6. Years of Practice (e.g. RNC): Yes No
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QUESTIONNAIRE
1. The most common opioid-related adverse complication is:
a. Respiratory Depression
b. Infection
c. Tolerance
d. Death
2. Historically, cardiac surgeries were associated with:
a. High death rates
b. High opioid induction
c. Regional anesthesia
d. Conservative opioid induction and maintenance
3. What percent of opioid-naïve patients who receive opioids intraoperatively become
chronic opioid users?
a. 2%
b. 10%
c. 15%
d. 8%
4. A patient had a successful valve replacement surgery 48 hours ago, this patient
received opioid-based anesthesia, and a total of 600 mcg of fentanyl
intraoperatively. Postoperatively the patient has been requiring opioids
(Fentanyl/Dilaudid) for breakthrough pain, which are now becoming more
frequent. The anesthesia provider rounds on the patient and realizes that these may
be signs related to:
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a. Normal postsurgical pain after open heart surgery
b. Clinical phenomena related to opioids (antinociceptive tolerance and
hyperalgesia)
c. Surgical complications
d. Inability to complete deep breathing exercises and lack of mobilization
5. Dexmedetomidine at 0.4mcg/kg/hr can reduce the need for postoperative opioid
consumption and has organ protective properties: True

False

6. The administration of the opioid methadone causes respiratory depression similar to
morphine or fentanyl: True

False

7. The lowering of pain thresholds that causes increases in atypical pain appearing to
be unrelated to the original nociceptive stimulus is known as?
a. Upregulation
b. Hypoalgesia
c. Hyperalgesia
d. Paresthesia
8. Regional anesthesia has been shown to be beneficial in reducing pain and opioid
requirements in cardiac patients. Which are true of the erector spinae plane block?
(SELECT 2)
a. Avoids major organs, safe approach
b. Allows for the insertion of epidural catheters for post-operative pain control
c. Unable to reach the sternum/ribs to provide significant pain relief
d. Provides 124 hours of pain control
9. What are some benefits to opioid-sparing approaches in cardiac surgery?
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a. Reduced opioid requirements intraoperatively and postoperatively
b. Decreased postoperative nausea and vomiting
c. Decreased incidence of atrial fibrillation
d. Increased need for invasive postoperative ventilation
e. Faster times to extubation
f. Increased organ protection during CPB
g. All except for d.
10. Traditional anesthetic management for cardiac surgery included high-opioid
inductions.
True False
11. According to the literature about erector spinae plane blocks in pediatric subjects,
the addition of epidural catheters for programmed intermittent boluses with 0.2%
ropivacaine can decrease postoperative opioid requirements for up to:
a. 12 hours
b. 24 hours
c. 48 hours
d. 72 hours
12. True or False: Methadone has properties that act on the NMDA receptor and avoids
hyperalgesia compared to morphine/fentanyl.
True

False
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Appendix F: QI educational module

Opioid-Sparing Anesthesia in
Cardiac Surgery
An educational module
Daniel Baez
Charles Buscemi
Florida International University

Learning Goals
•

Learn the differences between traditional opioid-based anesthesia and opioid-sparing anesthesia for cardiac
surgery

•

Learn about the benefits to implementing opioid-sparing anesthesia in cardiac surgery

•

The individual techniques used when implementing including regional anesthesia and pharmacological
therapy

•

Review the latest literature on opioid-sparing anesthesia from other cardiac facilities around the world.

•

Apply the knowledge in other patient populations
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Background of Problem
• Opioid overdoses are one of the leading causes of death, surpassing motor vehicle
accidents.1
• The CDC estimates the total economic burden of prescription opioid misuse in the United
States to be 78.5 billion dollars a year. 2
• Cardiovascular diseases are expected to rise within the next 5-10 years along with the
number of cardiac surgeries performed3
• Cardiac procedures are painful and are traditionally managed with the use of
intraoperative short-acting opioids such as fentanyl
• Up to 8% of opioid-naïve patients that are administered opioids during surgery may
become chronic users. 4

Cardiac surgery and Opioids
• Despite today's multi-modal approaches to anesthesia, the use of short-acting opioids
remain the pharmacological norm in cardiac surgery
• Historically, cardiac surgeries were associated with high-opioid inductions and
maintenance.5
• This caused awareness with the rise of opioid-related adverse events, and the need for
multi-modal pain control, ERAS protocols, and ‘Fast-Track’ approaches
• With the need for pain to be controlled, there is a fine balance between narcotic
administration and side effects which include:
• The most common is respiratory depression, then ileus, emesis, hyperalgesia, somnolence,
urinary retention, allodynia, hypercarbia, and death4
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Pain Control During Cardiac Surgery: A Delicate
Balance
• In cardiac surgery there is significant pain from median sternotomy, insertion of chest
tubes, costovertebral joint distention, saphenous vein grafting6
• Ineffective pain control during major cardiac surgery can lead to sympathetic activation
that results in unstable hemodynamics and an increased demand for oxygen6
• This is undesirable in cardiac patients with limited reserves 6
• Short acting opioids for this reason have been the mainstay of cardiac surgery
• However, what if we could achieve the same level of hemodynamic stability, address the
significant pain that is associated with open-heart cardiac surgery, and, also improve
patient outcomes such as extubation times and PONV?

Continued…
• The answer might be found in using opioid-sparing anesthesia in patients having openheart cardiac surgery
• The use of short-acting opioids are associated with two main clinical drawbacks including
• 1)antinociceptive tolerance, in which less analgesic effect is seen with equal
repeat doses
• 2)hyperalgesia, which causes a paradoxical decrease in the pain threshold. This
decrease in the pain threshold increases the incidence of atypical pain, which is pain that
is unrelated to the original nociceptive stimulus7
• The following six studies are centered on open-heart cardiac surgery requiring CPB with
measured outcomes during the intraoperative and postoperative periods in both adult
and pediatric open heart surgery patients
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Literature on Opioid Sparing Cardiac Surgery
Authors

Title

Evidence Level

Guinot et al. (2019)8

Effect of opioid-free anaesthesia on post- operative
period in cardiac surgery: a retrospective matched
case-control study

Retrospective matched cohort study, Level III

Aguerreche et al. (2021)9

Feasibility and postoperative opioid sparing
effect of an opioid-free anaesthesia in adult
cardiac surgery: a retrospective study

Retrospective review.
Level III

Kaushal et al. (2020)10

Efficacy of Bilateral Erector Spinae Plane Block in
Management of Acute Postoperative Surgical Pain
After Pediatric Cardiac Surgeries Through a Midline
Sternotomy

Prospective, randomized, single-blind,
comparative study
Level III

Macaire et al. (2020)11

Bilateral ultrasound-guided thoracic erector spinae
plane blocks using a programmed intermittent bolus
improve opioid-sparing postoperative analgesia in
pediatric patients after open cardiac surgery: a
randomized, double-blind, placebo-controlled trial

Randomized, double-blind, placebo-controlled
trial
Level III

Iguidbashian et al. (2020)12

Enhanced Recovery and Early Extubation after
Pediatric Cardiac Surgery Using Single-Dose
Intravenous Methadone

Retrospective analysis,
Level III

Ming et al. (2021)13

Effect of dexmedetomidine on perioperative
hemodynamics and organ protection in children with
congenital heart disease

Randomized Controlled Trial

Improving Patient Outcomes
with an Opioid-Sparing
Approach
IV
acetaminophen
postoperatively
q 6h

Bilateral Erector
Spinae Plane Block
with PIBs of
Ropivicaine 0.2%

Reduction in
opioid
consumption,
improved
patient
outcomes

NON-OPIOID
ADJUVANTS
Ketamine, lidocaine,
magnesium,
ketorolac,
gabapentin
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Dexmedetomidine
Infusion at
0.4mcg/kg offers
organ protection
against the stress of
CPB

Methadone IV
as an alternative
to short acting
opioids, d/t a
lower respiratory
profile
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Pre-op Implementation
• Gabapentin or pregabalin PO administered the night before surgery
• IV Tylenol preoperatively
• Dexmedetomidine infusion can be started preoperatively and is also good alternative
to midazolam in elderly patients to preserve cognitive function

• Methadone IV before sternal incision• Alternative to short acting opioids
• Long-acting opioid, great for treating basal surgical pain of cardiac surgery, can last
up to 36 hours.
• Safer side effect profile, as it avoids respiratory depression compared to
fentanyl/morphine family
• Unique in that it also acts on NMDA receptors involvement

IV Intraoperative Implementation
• VAA titrated to BIS (Iso, Sevo)
• Dexmedetomidine-based opioid-sparing anesthesia
• Start the infusion at 0.4mcg/kg/hr
• Good starting point for both adults and pediatrics
• Can be started in the pre-operative setting (especially in patients at risk for
POCD)
• Pharmacological profile decreases intraoperative opioid requirements
• Organ protectant- from the inflammatory stress response of surgery and from
CPB
• Standardize as part of the open-heart set up for optimal patient results

• Ketamine infusion and/or boluses
• Lidocaine and Magnesium infusions
• Regional anesthesia
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Regional Intraoperative Implementation
• Bilateral Erector Spinae Plane Block
•

Perform the ESPB block after the induction of anesthesia
• Good results in both adults and pediatrics
• Simple to perform, avoids large organs/blood vessels, easy to locate
landmarks
• Anesthetizes the dorsal and ventral rami of the spinal nerve roots
• Profound analgesia of the ipsilateral hemithorax
• 0.2% ropivacaine is typically used
• Without bilateral epidural catheters- can provide up to 12 hours of pain relief
• With the addition of bilateral epidural catheters, up to 48 hours of
postoperative pain control

Postoperative Implementation
• IV Tylenol
• 15mg/kg or 1g q 6 hours

• Programmed intermittent boluses of Ropivacaine via bilateral epidural catheters
• Up to 48 hours of pain control
• Reduction in morphine requirements

• Short acting IV opioids
• Fentanyl, Morphine, Hydromorphone
• Reserve for the treatment of breakthrough pain in efforts to improve post surgical
outcomes by decreasing opioid consumption
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Take home points
• The information presented today serves as a guide with improving the
knowledge of anesthesia providers in opioid-sparing techniques in openheart cardiac surgeries
• Open-heart surgery is very painful, which is why high-opioid
techniques have remained the norm
• Opioid-sparing anesthesia in major cardiac surgery is the topic of newer
research, demonstrating analgesic equipotency with improved patient
outcomes over opioid-based approaches
• Further research is needed for larger adoption as there is a large theory-topractice gap
• The addition of regional anesthesia further reduces the overall need for
perioperative opioids for up to 48 hours with the ESPB and epidural
catheters for postoperative pain control

Take home points
• A good alternative to shorter acting opioids (i.e Fentanyl) for open heart surgery is the
use of IV methadone prior to surgical incision to provide 36-hour pain relief without
respiratory depression or hyperalgesia/tolerance
• Dexmedetomidine infusion has many applications in cardiac surgery for both adults and
pediatrics and varies from open-heart surgery to TAVRs. Those include improved cognition and
a decreased incidence of postoperative agitation in the elderly, reduction in the incidence of afib arrythmias, organ protection from the physiological stress response of CPB, reduction in
morphine requirements, facilitation of deep, and on-table extubation, and lack of respiratory
depression/cessation with use
• With up to 8 percent of opioid-naïve patients possibly becoming chronic opioid users,
anesthesia providers can help combat this statistic, and help fight the opioid crisis
• The application of opioid-sparing anesthesia in cardiac surgery can become the future of
forward-thinking institutions and can be offered as an anesthetic option for the patient to
choose. (Think “GETA”/”RA”/”Opioid-sparing”)
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